Category: Licensing & Accreditation & Policy

Licensing guidance for all 50 states: Joint Commission and CARF accreditation, CARF 3.7 level of care, license restoration, policy, and audit readiness.

  • North Dakota Mental Health Outpatient Licensing

    North Dakota Mental Health Outpatient Licensing

    Author: A. Ant, CADC-II, Licensing & Accreditation Expert

    Disclaimer: This content is provided for general informational purposes only and should not be construed as legal, regulatory, or licensing advice. Requirements change frequently. Consult qualified professionals for guidance specific to your situation.

    When North Dakota’s Century Code lists the behavioral health duties of the Department of Health and Human Services, the only licensing job it names is “establishing quality assurance standards for the licensure of substance use disorder program services and facilities” (N.D.C.C. 50-06-01.4, the section that lays out the department’s structure). Outpatient mental health care gets no matching line. In practice that leaves a private counseling or psychiatric practice with no facility license to apply for, by our reading, while two narrower organizational routes do exist: HHS certification for a certified community behavioral health clinic, and the license that covers the state’s own behavioral health clinics.

    Where the Statute Stops

    This section is our interpretation of the statutes and HHS pages it cites. HHS has not said it in those words.

    We looked for an outpatient mental health license in the places one would sit. The facility types on HHS’s public health licensing page include ambulatory surgical centers, basic care, home health, hospice, hospitals and rural health clinics, among others, while the behavioral health link on the department’s licensing hub leads to the substance use program page. On that page, the words “mental health” turn up only inside the name of the federal Substance Abuse and Mental Health Services Administration. Article 75-05 of the Administrative Code, Human Service Center Licensure Standards, deals with the state-run centers. The commitment act, N.D.C.C. 25-03.1, recognizes private treatment facilities only if they are licensed as hospitals or SUD programs.

    Put together, those sources leave no state license that a private outpatient mental health program could apply for, as far as we can tell. The regulation an office practice actually feels comes through its clinicians’ individual licenses, its business registration and, if it ever adds addiction treatment, the Behavioral Health Division (BHD). Because absence is hard to prove, a short written question to HHS before opening is cheap insurance.

    Outpatient Mental Health Models and What Each Needs

    Rows restate the statute or rule named, except the first, which is our reading.

    ModelState approvalGoverning textWorth knowing
    Private therapy or psychiatric practiceNo facility license foundClinicians’ own board licensesConfirm with HHS before opening
    Certified community behavioral health clinic (CCBHC)HHS certificationN.D.C.C. 50-06-41.4Certification rules must include a need assessment for the proposed site
    State-operated behavioral health clinicHHS license or certificationN.D.C.C. 50-06-05.2Applies to the former regional human service centers, and HHS may license on accreditation
    Practice that adds SUD outpatient or IOP servicesBHD program licenseN.D.C.C. 50-31, NDAC 75-09.1-06 and -07SFN 971 application, $150 nonrefundable fee

    The CCBHC row is the newest. SB 2113, signed May 2, 2025, wrote it into the code, and N.D.C.C. 50-06-41.4 now reads “To operate in this state, a certified community behavioral health clinic must be certified by the department.” The need assessment is the part that surprises people, since North Dakota has otherwise repealed its certificate of need law. A clinic that never calls itself a CCBHC is outside this section. A separate funding relationship with HHS sits outside licensing too, and we do not handle it.

    Adding Substance Use Services to a Therapy Practice

    This is where a mental health practice most often crosses into licensing. N.D.C.C. 50-31-02 says a person “may not establish, conduct, or maintain in this state a substance use disorder treatment program” without a license. Nothing in chapter 50-31 carves out exemptions, and its definitions section never says what counts as a substance use disorder treatment program, so we cannot point you to a written carve-out for a therapist who sees a few clients with addiction issues. BHD describes itself as licensing “all substance abuse treatment programs in North Dakota,” and the same page asks a counselor who is “applying as a private practice” for confirmation of registration from the counselor board. That counselor also needs board registration to practice privately at all, because N.D.C.C. 43-45-05.3 says a person “may not engage in the private practice of addiction counseling” without it.

    Our reading is that a practice planning a defined addiction track, such as Level I outpatient or Level II.1 intensive outpatient, should expect a BHD license. Put the question to BHD (dhsbhd@nd.gov, 701-328-8920) before the service is advertised, and see North Dakota Drug and Alcohol Outpatient Treatment Licensing for the application itself. One 2025 change helps blended practices. SB 2079 made licensed addiction counselors “tier 2b” mental health professionals, so an LAC on a mixed team now holds a recognized mental health professional tier as well.

    Ketamine and Spravato in a North Dakota Outpatient Practice

    No North Dakota statute or rule addresses ketamine in an office practice. The analysis below is our reading of the nursing board guidance, Board of Nursing rules, the PDMP statute and the federal sources cited.

    With no facility license in the picture, ketamine or Spravato in an outpatient mental health office is part of the prescriber’s own practice. We also found no North Dakota license category for an office ketamine clinic. That moves the real compliance work onto the drug and the people handling it.

    Registration comes first. Ketamine is listed in Schedule III (21 CFR 1308.13(c)(7)), and under 21 CFR 1301.12 every principal place of professional practice where controlled substances are dispensed carries its own DEA registration. A practice that stocks ketamine at two offices plans for two registrations. No primary source we found says whether a North Dakota practitioner needs a state controlled substance registration in addition to the DEA one, so ask the State Board of Pharmacy before ordering stock.

    Nurse practitioners are a real option here. Under NDAC 54-05-03.1-09 an APRN gets prescriptive authority through a separate Board of Nursing authorization, with a $75 fee and 30 contact hours of pharmacotherapy education, and the rule text we read sets no collaboration or supervision requirement. Our reading is that an authorized APRN prescribes on their own license. That APRN must check the PDMP for any new patient who needs a controlled substance, every six months while treatment with a controlled substance continues, and whenever misuse is suspected. The PDMP itself belongs to the State Board of Pharmacy under chapter 19-03.5, and that chapter excludes a practitioner who “administers a controlled substance to a patient” from the definition of a dispenser. Doses given in the office therefore look outside dispenser reporting to us, though the Board of Pharmacy is the one to confirm it.

    Who gives the dose matters more in North Dakota than in many states. The Board of Nursing’s January 2026 sedation and analgesia guidance puts anesthetic agents such as ketamine “for analgesia/sedation” outside the scope of RNs and non-CRNA APRNs except in listed situations, and leaves LPNs out entirely. It says nothing direct about psychiatric dosing. An office planning IV ketamine should get the Board’s view before assigning infusions to nursing staff. For Spravato, the boxed warning on the FDA label says “patients must be monitored for at least 2 hours at each treatment session,” and the drug “is available only through a restricted program under a REMS called the SPRAVATO REMS.”

    Ownership is the open question. North Dakota has no statute, rule or appellate medical decision on corporate practice of medicine that we could find, only a 1990 Attorney General letter, not binding, that described the state’s public policy as barring a non-professional corporation from employing physicians and left any prosecution to the judgment of each state’s attorney. Our position is that the law is unsettled. The ketamine section of North Dakota Drug and Alcohol Outpatient Treatment Licensing walks through the ownership setups a stand-alone clinic tends to use, and a North Dakota health care attorney should look at any investor-owned model.

    Staffing a North Dakota Outpatient Practice

    Pay runs higher here than nationally. BLS puts North Dakota’s substance abuse, behavioral disorder and mental health counselors at a $68,630 median, a 25th percentile of $55,450 and a 75th of $77,320 (BLS OEWS, May 2025). The country-wide median from that release is $59,350. Two clinicians at the state median add up to about $137,260 in yearly base pay by our math, before benefits and before a supervising clinical lead. That gap above the national figure is manageable for a practice that hires with its supervision structure in mind. If the practice runs an addiction track, it can hire people still logging the 960 clinical training hours the LAC demands, since the counselor board allows a year of registered trainee status for that work. With a licensed counselor supervising them at trainee wages, the addiction side of payroll commonly comes in 40 to 60 percent lower than it would with licensed counselors only. Social work, counseling and psychology each have their own board and supervised tiers, which fall outside this guide. If the practice adds a medication service with nursing, one RN directing LPNs on tasks within LPN scope costs less than an all-RN staff. The service mix you settle on decides the final roster.

    What Trips Up North Dakota Outpatient Practices

    Most of the trouble starts with an addiction track added informally, a group or two at first, without anyone asking BHD whether that is now a substance use disorder treatment program. The other recurring problem is ketamine staffing, where an office assumes its RNs can run infusions and only later reads the Board of Nursing’s sedation guidance.

    Frequently Asked Questions

    Is there a North Dakota facility license for a private therapy or psychiatry practice?

    Not that we could find. N.D.C.C. 50-06-01.4 names licensure standards for substance use disorder programs only, HHS’s public health licensing list has no mental health clinic category, and NDAC Article 75-05 covers state-run human service centers. The clinicians’ individual licenses carry the regulation. That is our reading, so put the question to HHS in writing before opening.

    What is CCBHC certification in North Dakota?

    N.D.C.C. 50-06-41.4, created by SB 2113 (signed May 2, 2025), requires a certified community behavioral health clinic to be certified by HHS before it operates. The statute tells HHS to include an assessment of need in the proposed location in its certification rules. A practice that does not operate as a CCBHC is not covered.

    When does a North Dakota therapy practice need a BHD license?

    When it operates a substance use disorder treatment program, which N.D.C.C. 50-31-02 bars without a license. The chapter has no exemption section, so a practice planning a defined addiction service such as outpatient or intensive outpatient should expect to file SFN 971 with BHD and pay the $150 fee. Ask BHD at dhsbhd@nd.gov to confirm your model.

    Thinking about adding an addiction track or a ketamine service to a North Dakota practice? Start the conversation here.

    Sources

  • North Dakota Mental Health Inpatient Licensing

    North Dakota Mental Health Inpatient Licensing

    Author: A. Ant, CADC-II, Licensing & Accreditation Expert

    Disclaimer: This content is provided for general informational purposes only and should not be construed as legal, regulatory, or licensing advice. Requirements change frequently. Consult qualified professionals for guidance specific to your situation.

    North Dakota puts its psychiatric inpatient rules inside the hospital licensing chapter, and one sentence in that chapter decides who is covered. NDAC 33-07-01.1-36 says “Any facility that provides or purports to provide psychiatric inpatient or inpatient and outpatient diagnosis or treatment on other than an emergency basis shall comply with this section.” The same section bars primary care hospitals from offering psychiatric services at all and requires a North Dakota licensed psychiatrist to be in charge. The HHS Health Facilities Unit administers it. Outside a hospital, we could not find a license for an adult mental health residence at all.

    Three 24-Hour Settings Compared

    The first and third columns restate the statutes and rules named in them. The middle column is our reading of what is missing from those sources.

    ItemPsychiatric hospital or hospital psychiatric serviceNon-hospital adult mental health residenceFreestanding SUD program at Level III.7
    LicenseHospital license, psychiatric as a specialized hospital type (N.D.C.C. 23-16, NDAC 33-07-01.1)No separate state license foundBHD license under N.D.C.C. 50-31 and NDAC 75-09.1-04, with no hospital license needed (N.D.C.C. 23-16-01)
    OfficeHHS Health Facilities UnitNone identifiedHHS Behavioral Health Division
    State fee$10 for each licensed acute care bed, charged to hospitals that are not government facilitiesNone identified$150 nonrefundable application fee
    License termAnnual. A provisional license can run 90 days or less and be renewed twice at mostNone identifiedProvisional up to one year, unrestricted up to two years
    Who must lead clinicallyA psychiatrist licensed in North Dakota in charge of psychiatric servicesNone identifiedPhysician services 24 hours a day, seven days a week
    Certificate of NeedNone (N.D.C.C. 23-17.2 is repealed)NoneNone
    Daily bed report to HHSYes (N.D.C.C. 50-06-41.3)The statute reaches private providers of residential behavioral health servicesYes

    What NDAC 33-07-01.1-36 Asks of a Psychiatric Service

    Quoted from the Legislative Branch’s copy of the rule. Section -36 took effect April 1, 1994 and was last amended January 1, 2024.

    The section works as a gate before it works as a standard. “A hospital may not hold itself out to the public as providing psychiatric services unless such psychiatric service has been licensed by the department and meets the requirements for a psychiatric hospital in this section.” So a general acute hospital that wants to open a behavioral health wing needs that service licensed, and a primary care hospital cannot do it at all, since the rule says flatly that “Primary care hospitals may not provide psychiatric services.”

    Leadership is spelled out. “The physician in charge of the psychiatric services must be a psychiatrist who is licensed to practice medicine in North Dakota,” and psychiatrists on the service need three years of approved psychiatry residency or the equivalent. Recruiting that person tends to set the opening date more than anything on the paperwork side. The section also carries restraint, seclusion and discharge provisions. We have not summarized those here, so read them in the rule itself before writing policy.

    Accreditation enters twice. Under 33-07-01.1-06, “A hospital may request that the department consider it in compliance with this chapter” if it meets the standards of a nationally recognized accrediting agency, and “For those portions of the accrediting agency survey report which the department accepts,” the hospital is treated as meeting the matching licensure requirements. HHS can still monitor anything the accreditor does not review, and a denial of accreditation brings an onsite state survey. Section -36 then adds a reporting duty: “Hospitals accredited by a national accrediting entity in the category of psychiatric services shall submit, upon receipt, all accreditation survey results, recommendations, and plans of correction to the department.”

    Adult Mental Health Residences Outside a Hospital

    This section is our interpretation, built from the statutes and HHS pages listed in the Sources. No HHS office has told us this in writing.

    Operators from states with a residential mental health license usually go looking for North Dakota’s version. We did not find one. No mental health program category appears on HHS’s public health licensing list. NDAC Article 75-05 is titled Human Service Center Licensure Standards, and its license requirement points to N.D.C.C. 50-06-05.2, which now calls those centers state-operated behavioral health clinics. Private programs are not its subject. The commitment statute, N.D.C.C. 25-03.1-02, defines a “private treatment facility” as one “licensed under chapter 23-16 or 50-31,” meaning a hospital or an SUD program. Read together, those sources suggest that 24-hour psychiatric treatment in North Dakota is either a hospital service or, where addiction is the primary problem, a BHD-licensed SUD program.

    Two loose ends deserve a phone call before you sign a lease. HHS’s public health licensing page lists basic care facilities, assisted living and a summary of standards for non-medical residential facilities, and we have not tested whether a group residence for adults with mental illness would fit any of them. And if the residents’ primary need is substance use treatment, the program belongs on a BHD license at Level III.1, III.5 or III.7, which North Dakota Drug and Alcohol Inpatient Treatment Licensing covers. Any residential or inpatient behavioral health provider, public or private, also owes HHS’s bed management system a daily report under N.D.C.C. 50-06-41.3.

    Ketamine on a North Dakota Psychiatric Unit

    Ketamine appears nowhere in the hospital rule or chapter 23-16, so the points below rest on our reading of the North Dakota Board of Nursing’s January 2026 guidance, federal hospital and drug rules, and the Spravato label.

    If a ketamine or esketamine series is going to begin during a North Dakota inpatient stay, the licensed psychiatric service is the setting built for it. Under the federal hospital pharmacy standard at 42 CFR 482.25, the medical staff owns the formulary (“A formulary system must be established by the medical staff”), and every scheduled drug needs a paper trail, since “Current and accurate records must be kept of the receipt and disposition of all scheduled drugs.” Ketamine sits in Schedule III (21 CFR 1308.13(c)(7)). Spravato adds its own conditions: the FDA label says it “is available only through a restricted program under a REMS called the SPRAVATO REMS,” and “patients must be monitored for at least 2 hours at each treatment session.”

    Nursing is where North Dakota differs. The Board of Nursing’s January 2026 update of Role of the Nurse in Sedation/Analgesia lists ketamine with propofol, methohexital and etomidate and treats giving them “for analgesia/sedation” as “outside the scope of practice for nurses EXCEPT” in four situations. The one a psychiatric unit could realistically use is a CRNA or anesthesiologist being present. The guidance covers RNs and APRNs who are not CRNAs, and it keeps LPNs out of sedation and analgesia altogether. It does not address low-dose ketamine given for depression. Our reading is that a unit should not assume RN-run infusions are allowed. Either build the protocol around one of the listed exceptions or get the Board’s written view first. The Board has fielded ketamine questions before. Its October 28, 2021 minutes record providers asking about ketamine for pain in non-intubated critical care patients, so a direct question is not unusual.

    People held under the commitment act need a separate decision. We have not worked through how chapter 25-03.1 treats consent to a medication like ketamine. A first protocol limited to voluntary adults who sign their own consent is the cautious starting point, and extending it to anyone else is a question for the hospital’s counsel.

    Arrange the Outpatient Prescriber Early

    A ketamine series rarely ends with the inpatient stay, so pick the outpatient prescriber early in the stay and, once the patient signs a release, forward dosing records and notes on how the patient responded along with the discharge paperwork. That prescriber picks up North Dakota’s monitoring rules. The PDMP is run by the State Board of Pharmacy, and chapter 19-03.5 leaves a practitioner who “administers a controlled substance to a patient” out of the definition of a dispenser. Our reading is that in-office doses are not dispenser-reported, but confirm that with the Board of Pharmacy. If that prescriber is an APRN with prescriptive authority, Board of Nursing rules require a PDMP query before prescribing a controlled substance to someone new to the practice, a repeat query every six months, and another whenever misuse is a concern.

    Ownership of the outpatient practice is unsettled here. We found no North Dakota statute, rule or appellate medical case on corporate practice of medicine. What exists is a letter the Attorney General sent to Cass County’s prosecutor on October 23, 1990. It reads state public policy as barring a corporation other than a professional corporation “from employing physicians to provide medical care,” yet it binds no one and leaves any criminal charge to local prosecutors. In our view a physician-owned practice that buys nonclinical services from a management company avoids the issue, and a North Dakota health care attorney should review any other structure. For how a stand-alone clinic gets set up, see North Dakota Drug and Alcohol Outpatient Treatment Licensing.

    Budgeting Clinical Staff for a Psychiatric Service

    The psychiatrist in charge is the fixed cost, and the nursing schedule is the large one. For therapists and counselors, BLS (OEWS, May 2025) reports a $68,630 median for North Dakota’s substance abuse, behavioral disorder and mental health counselors, and a quarter of them earn $55,450 or less while a quarter earn $77,320 or more. The national figure in that release is $59,350. Our arithmetic puts five clinicians at the state median near $343,150 a year in base pay. A North Dakota unit has two levers that keep that number from running away. For co-occurring caseloads, North Dakota’s addiction counselor rules give a trainee up to 12 months of registered trainee status to finish the 960 clinical training hours the LAC requires, and an LAC who supervises those trainees at their lower pay rate commonly shaves 40 to 60 percent from that slice of the clinical budget compared with hiring licensed counselors for every seat. Social workers, counselors and psychologists have their own boards and supervised tiers, which this guide does not cover. Nursing follows the same logic, since an RN charge nurse on each shift leading LPNs is cheaper than staffing the floor entirely with RNs, keeping in mind that the Board of Nursing places sedation and analgesia outside LPN scope. Bed count and acuity decide the real roster.

    What Slows North Dakota Inpatient Mental Health Projects

    Hiring the psychiatrist who will run the service is the usual bottleneck, and nothing can be licensed without that person named. The second stall is quieter. A group plans a stand-alone adult mental health residence, spends weeks looking for the license to apply for, and only then learns that the realistic choices are a hospital service, an SUD program under BHD, or a model HHS has to weigh in on directly.

    Frequently Asked Questions

    Does North Dakota license residential mental health programs for adults?

    Not as a separate category that we could find. Inpatient psychiatric care is licensed as a hospital service by the HHS Health Facilities Unit under NDAC 33-07-01.1-36, and the commitment statute defines a private treatment facility as one licensed under chapter 23-16 (hospitals) or 50-31 (SUD programs). We reached that from the statutes and HHS pages rather than any HHS statement, so ask HHS about any non-hospital model before committing to it.

    What fee and license term apply to a North Dakota psychiatric hospital?

    Chapter 23-16 sets the fee at $10 per licensed acute care bed for hospitals that are not government facilities, and the license expires one year after it is issued. If HHS issues a provisional license instead, it runs 90 days at most and can be renewed only twice. The Health Facilities Unit answers at (701) 328-2352.

    Does a new psychiatric bed in North Dakota go through Certificate of Need review?

    No. Chapter 23-17.2, the old review for expanding hospital facilities, appears as repealed, and the one moratorium in chapter 23-16 freezes nursing facility beds only, for a window that runs August 1, 2025 to July 31, 2029.

    Sizing up a psychiatric service or a residential mental health idea in North Dakota? Tell us what you have in mind.

    Sources

  • North Dakota Drug and Alcohol Outpatient Treatment Licensing

    North Dakota Drug and Alcohol Outpatient Treatment Licensing

    Author: A. Ant, CADC-II, Licensing & Accreditation Expert

    Disclaimer: This content is provided for general informational purposes only and should not be construed as legal, regulatory, or licensing advice. Requirements change frequently. Consult qualified professionals for guidance specific to your situation.

    Apply now: SFN 971 license application (PDF) | Questions: Behavioral Health Division, dhsbhd@nd.gov or 701-328-8920

    An outpatient addiction program in North Dakota that already holds national accreditation is in an unusually good position. NDAC 75-09.1-01-25 doesn’t say the state “may” license an accredited program. It says “The department shall issue a license to a program that has a current accreditation of a nationally recognized body that reviews and certifies providers of drug and alcohol services.” That is firmer wording than we usually see in state SUD rules. The license still comes from the Behavioral Health Division (BHD) of the Department of Health and Human Services, and it still requires an application, but the accreditation survey you already passed carries real weight in the decision.

    Residential levels, the freestanding 3.7 exemption and the medication rules for a residence are in North Dakota Drug and Alcohol Inpatient Treatment Licensing. For mental health clinics and the state’s full licensing map, see North Dakota Behavioral Health Licensing.

    What Accreditation Does and Doesn’t Buy

    The rule text quoted here is from NDAC chapter 75-09.1-01 and N.D.C.C. 50-31-04, both read on the Legislative Assembly’s site. How BHD applies them in practice is something we flag as unconfirmed.

    When you apply or renew, 75-09.1-01-25(2) has you hand over “proof of accreditation or deemed status in the form of the accreditation agency’s most recent review and certification.” BHD’s provider booklet describes the result as a deemed-status license “valid up to two years.” The rule doesn’t name accreditors. We read CARF and The Joint Commission as fitting “a nationally recognized body,” but BHD hasn’t said that in writing, so confirm yours before relying on it.

    The visits don’t disappear. Section 75-09.1-01-03 requires BHD to conduct “continued license reviews for programs with unrestricted licenses on at least a biennial basis” and contains no exception for accredited programs. Section 50-31-04 of the Century Code adds that the department “shall evaluate every licensed substance use disorder treatment program.” HHS’s 2024 draft rewrite says a program with active accreditation at renewal “may be exempt from the site visit requirement per the discretion of the department,” but that is draft language, and the current rules contain nothing like it. Our advice is to expect BHD onsite and to treat accreditation as the thing that secures the license itself.

    Three Outpatient Levels, Defined by Weekly Hours

    Article 75-09.1 gives each adult outpatient level its own chapter and draws the line between them by programming hours per week. The figures below come straight from those chapters.

    LevelNDAC chapterWeekly programmingStaffing language in the rule
    Level I outpatient75-09.1-07No more than 8 hours (fewer than 9 contact hours)Counseling and assessment by a licensed addiction counselor, who also attends team meetings
    Level II.1 intensive outpatient75-09.1-068 to 19 hoursMedical and nursing services as the assessment and treatment plan call for
    Level II.5 partial hospitalization or day treatment75-09.1-05At least 20 hoursMultidisciplinary staff, plus medical and nursing services as assessed

    A program running both an evening IOP track and weekly aftercare groups is licensed for both levels, and SFN 971 has a checkbox for each. The DUI seminar at Level 0.5 (75-09.1-09) is a separate box as well. Under 75-09.1-01-02, adding a level later means a new application, not a phone call.

    Solo Counselors and Private Practice

    North Dakota’s program license reaches private-practice addiction counselors too. BHD’s licensing process page tells an addiction counselor “applying as a private practice” to supply confirmation of registration and licensure from the board, which in our reading means a solo LAC practice goes through BHD with SFN 971 like any clinic. The board side is set by N.D.C.C. 43-45-05.3: “A person may not engage in the private practice of addiction counseling unless that person” is registered with the Board of Addiction Counseling Examiners. Chapter 50-31 has no exemptions section and doesn’t define what counts as a treatment program, so a counselor working inside a medical or mental health practice should ask BHD directly whether the practice needs its own license.

    No Certificate of Need for Outpatient Care

    The Century Code lists chapter 23-17.2, North Dakota’s old certificate of need law for hospital expansion, as repealed. An outpatient SUD clinic needs no need review from the state. The one outpatient service with a step BHD itself calls a “Certificate of Need” is an opioid treatment program, whose first licensing stage goes to the State Opioid Treatment Authority. That track is separate from the license described here.

    Buprenorphine, Methadone and the Draft MOUD Rule

    Office-based buprenorphine is the simplest medication pathway an outpatient program can add. The DEA’s January 2023 notice says the DATA-Waiver is no longer required and that “all prescriptions for buprenorphine only require a standard DEA registration number.” Methadone for opioid use disorder belongs to opioid treatment programs, which BHD licenses one location at a time under N.D.C.C. 50-31-08. A clinic that doesn’t run one should name the OTP its clients use and put the coordination arrangement on paper.

    Current chapter 75-09.1-01 has no provision we found requiring an outpatient program to allow MOUD. HHS’s pending draft would require it, with the line “A program shall allow the use of medications approved by the Food and Drug Administration,” and would add a Level 1.7 medically managed outpatient chapter. HHS’s draft rules page now anticipates “July 1, 2027, pending completion of the formal rulemaking process and required approvals.” None of it is in force today, so treat Level 1.7 as a planning signal, not a license you can apply for.

    Opening a Ketamine Clinic in North Dakota

    North Dakota has no ketamine clinic statute. On facility licensing and ownership, what follows is how we read HHS’s licensing list and a 1990 Attorney General letter. The nursing, DEA, PDMP and Spravato points rest on the board guidance, federal rules and statute linked in each paragraph.

    HHS’s licensing, regulation and certification hub names facility types such as ambulatory surgical centers, rural health clinics and hospitals, plus a separate behavioral health link that leads to the SUD program license. No category fits a physician office that gives ketamine for depression. Our conclusion is that a clinic of that kind needs no state facility license, which leaves the drug, the clinicians and the owners as the regulated parts. A clinic that also treats addiction is different, because SUD treatment brings it back under chapter 50-31.

    Ownership Without a Settled Rule

    Corporate practice of medicine in North Dakota rests on thin authority, with nothing in the Century Code, the Administrative Code or the state’s appellate reports that we could find. A 1990 letter from the Attorney General to the Cass County State’s Attorney concluded that “North Dakota public policy prohibits a corporation, other than a professional corporation,” “from employing physicians to provide medical care,” and said the call on any crime “must be left to the state’s attorney in each and every case.” It is an advisory letter, not a binding opinion or a court decision, so the question stays open as far as we can tell. The structure we recommend anyway is a professional practice whose owner is a physician licensed in North Dakota, contracting with a management services organization for space, staff and billing, with the clinical calls and the controlled substance registration staying with the practice. We did not review North Dakota’s professional entity statute for this guide, so have counsel confirm who may hold equity in the practice entity.

    Nurse practitioners have their own prescribing route. The Board of Nursing grants prescriptive authority separately, after a graduate APRN program and 30 contact hours of pharmacotherapy, and NDAC 54-05-03.1-09 sets no collaboration or supervision condition. We read that as letting an APRN with prescriptive authority order ketamine independently. Whether an APRN may own the practice is a separate entity question we left unconfirmed.

    Who Can Push the Dose

    This is the point where North Dakota’s rules bite hardest. The Board of Nursing guidance on sedation and analgesia, updated January 2026, puts ketamine given “for analgesia/sedation” “outside the scope of practice for nurses” unless one of its listed exceptions applies, the first being a CRNA or anesthesiologist present. The guidance treats RNs and non-CRNA APRNs as “nurses” for this purpose and says the practice “is not within the scope of the LPN.” It never mentions psychiatric dosing. Until the board says otherwise, our suggestion is a clinic model where a physician or a CRNA is in the room for infusions, with RNs handling monitoring tasks the guidance doesn’t restrict.

    Controlled Substance Rules for the Clinic

    On the federal list, ketamine is a Schedule III substance (21 CFR 1308.13(c)(7)). Under 21 CFR 1301.12, DEA requires a separate registration for each principal place of professional practice, so a second clinic location means a second registration. We found no Board of Pharmacy page saying whether North Dakota also wants its own controlled substance registration alongside DEA’s, so call the board. The state’s PDMP statute, N.D.C.C. 19-03.5-01, excludes a practitioner from the dispenser definition “when the practitioner administers a controlled substance to a patient,” so in our reading in-clinic infusions aren’t reportable dispensing. APRN prescribers still have the PDMP check duties in NDAC 54-05-03.1-10(4), including for a “New or unestablished client requiring prescription for controlled substance.” A Spravato service needs REMS certification: the FDA-approved Spravato labeling says “Patients treated in outpatient healthcare settings (such as medical offices and clinics) must be enrolled in the program,” and each patient is monitored for at least 2 hours after a dose.

    Many clinic patients will arrive mid-series from a residential stay. The referral rules for that handoff, including BHD’s fee-splitting rule and the federal kickback statute, are in the ketamine section of North Dakota Drug and Alcohol Inpatient Treatment Licensing.

    Staffing an Outpatient Program

    The Level I chapter is specific about who does what. Under 75-09.1-07-03(5), counseling or assessment about alcohol or drug use “must be provided by a licensed addiction counselor,” an LAC has to be present in team meetings that decide level of care and treatment plans, and case management and educational services don’t need an LAC. The IOP and day treatment chapters say less, asking for multidisciplinary staff and medical and nursing services as the treatment plan requires.

    Budget against a high state wage. North Dakota’s median for substance abuse, behavioral disorder, and mental health counselors is $68,630 a year according to BLS OEWS for May 2025, compared with $59,350 nationally. The state’s 25th percentile is $55,450 and its 75th is $77,320. A clinical director plus three counselors, all paid at the median, comes to about $274,520 a year in clinical salary before benefits (4 x $68,630, our estimate). That number shrinks quickly once you use the training tier North Dakota’s counselor rules already provide. The Board of Addiction Counseling Examiners is where clinical trainees register, and a trainee may stay in that status up to twelve months (with up to twelve more at the supervisor’s request) while logging the 960 hours of clinical training required for an LAC under NDAC 4.5-02.1-01. An LAC clinical director overseeing trainees at trainee pay, while they earn those hours, usually brings counseling payroll down somewhere in the 40 to 60 percent range relative to a roster made up entirely of LACs. Where the program offers medication services, one RN supervising LPNs is the usual nursing model, keeping in mind that sedation work stays off the LPN’s task list. The exact hires depend on which levels you run and how many groups a week you schedule.

    How to Submit Your BHD Outpatient Application

    Every outpatient level uses SFN 971 (revision 2-2026), signed in front of a notary, with its Section 4 attestation and disclosure completed. BHD wants a policy and procedure manual covering Article 75-09.1, Secretary of State registration, the licensed addiction counselors you will use and the name of the responsible entity. A private-practice counselor also includes the board registration. The completed packet is mailed to the Behavioral Health Division, 600 E Boulevard Ave, Dept. 325, Bismarck, ND 58505-0250, and emailed to dhsbhd@nd.gov. BHD’s licensing page says: “For any questions, please contact the Behavioral Health Division at dhsbhd@nd.gov or 701-328-8920.”

    Two statutes touch the fee. N.D.C.C. 50-31-03.1 requires “a one hundred fifty dollar nonrefundable fee” with every application, and 50-06-01.7 separately lets BHD set nonrefundable licensing application fees “not to exceed three hundred dollars.” Neither SFN 971 nor the BHD licensing page states an amount, so ask BHD what it currently collects and how. The page also says “An initial review of the application and policy manual may take up to 6 weeks.” Our estimate for an outpatient program from filing to a license is 2 to 4 months, allowing for a round of policy revisions and the onsite review that moves a provisional license to an unrestricted one.

    Common Outpatient Setbacks

    Most delays we see trace back to the manual. Policies that don’t match the hour limits for the level checked on SFN 971, such as an IOP schedule that drops under 8 hours a week, draw revision requests. The other recurring problem is staffing on paper only. BHD asks you to name your licensed addiction counselors, and a program that lists one LAC for several levels may be asked how that person also attends every treatment planning meeting the Level I rule requires.

    Frequently Asked Questions

    Does an accredited outpatient SUD program in North Dakota still need a BHD license?

    Yes, but accreditation takes the discretion out of the decision. Under NDAC 75-09.1-01-25 the department must license a program accredited by a nationally recognized body that reviews drug and alcohol services. You still file SFN 971 with the accreditor’s most recent review, and the rules still call for BHD onsite reviews at least every two years.

    How many hours a week can a North Dakota IOP run?

    Level II.1 intensive outpatient under NDAC 75-09.1-06 must offer no less than 8 and no more than 19 hours of programming a week. Level I outpatient is capped at 8 hours, and Level II.5 day treatment or partial hospitalization starts at 20 hours.

    What does a North Dakota outpatient SUD license cost?

    N.D.C.C. 50-31-03.1 sets a 150 dollar nonrefundable application fee. A separate statute, 50-06-01.7, lets the Behavioral Health Division set application fees up to 300 dollars, and neither SFN 971 nor BHD’s licensing page lists an amount, so confirm the current fee with BHD before filing.

    Mapping your North Dakota outpatient levels to the right chapters before you file? Get in touch.

    Sources

  • North Dakota Drug and Alcohol Inpatient Treatment Licensing

    North Dakota Drug and Alcohol Inpatient Treatment Licensing

    Author: A. Ant, CADC-II, Licensing & Accreditation Expert

    Disclaimer: This content is provided for general informational purposes only and should not be construed as legal, regulatory, or licensing advice. Requirements change frequently. Consult qualified professionals for guidance specific to your situation.

    Apply now: SFN 971, Substance Abuse Treatment License Application (PDF) | Questions: HHS Behavioral Health Division, dhsbhd@nd.gov, 701-328-8920

    A medically monitored ASAM Level 3.7 program in North Dakota does not have to become a hospital. Since the 2023 session, the hospital licensing chapter itself says so. House Bill 1050 added language to N.D.C.C. 23-16-01 stating that “American society of addiction medicine level 3.7 substance use treatment programs” “licensed by the department of health and human services that are independent from a medical hospital” “are not required to obtain a license under this chapter.” So a freestanding 3.7 unit, with its round-the-clock physician services and 24-hour skilled nursing, answers to one office, the Behavioral Health Division (BHD) of the North Dakota Department of Health and Human Services, and not to the Health Facilities Unit that surveys hospitals.

    This guide covers adult residential care and social detoxification. Counseling, IOP and day treatment are in North Dakota Drug and Alcohol Outpatient Treatment Licensing, and the state’s other license tracks, including psychiatric hospitals, are summarized on the North Dakota Behavioral Health Licensing page.

    The 2023 Carve-Out for Freestanding 3.7 Programs

    The statutory language and bill history below come from the Legislative Assembly’s own code and session law files. The effective date is our reading of the state constitution, because the bill doesn’t print one.

    HB 1050 became Session Laws 2023, chapter 250. The governor approved it on March 14, 2023, and it was filed with the Secretary of State on March 15. The chapter has no emergency clause and no date of its own, and Article IV, section 13 of the North Dakota Constitution says a law takes effect “on August first after its filing” unless something else applies. We therefore treat August 1, 2023 as the date the exemption started.

    The same bill also amended several sections of chapter 50-31, the SUD licensing statute, mostly to swap “substance abuse” for “substance use disorder.” One older requirement in 50-31-04 deserves early attention, because the bill kept it in place: every licensed program must “obtain and provide to the department a local or state authority certification as to the safety of the premises.” For a residential building that usually means a fire or building official signs off before BHD will treat the file as complete, in our experience, so book that inspection early.

    The exemption has limits. It reaches a 3.7 program that is licensed by HHS and “independent from a medical hospital.” A unit run inside a hospital stays under hospital licensing (N.D.C.C. ch. 23-16 and NDAC ch. 33-07-01.1), and nothing in the carve-out touches psychiatric beds.

    Residential Levels the Rules Recognize

    NDAC Article 75-09.1 is organized by ASAM level, one chapter apiece. The adult residential chapters are 75-09.1-02 (Level III.1, clinically managed low-intensity), 75-09.1-03 (Level III.5, clinically managed high-intensity) and 75-09.1-04 (Level III.7, medically monitored intensive inpatient). Withdrawal management outside a hospital has a single chapter, 75-09.1-08, titled “Social Detoxification ASAM Level III.2-D.” We found no separate chapter for medically monitored or medically managed withdrawal, so a program planning medically supervised detox beds should raise that with BHD before designing the unit. SFN 971 asks you to tick each level you want, from 0.5 through 3.7.

    The rules still write levels in Roman numerals, the older ASAM style, but III.7 and 3.7 are the same level. That matters if a referral source wants outside proof of the level you run. CARF’s ASAM Level of Care Certification “is available for adult Levels of Care 3.1, 3.5, and 3.7,” and ASAM describes it as delivered “in partnership with CARF International.” North Dakota doesn’t require it and BHD’s license won’t print it. A hospital discharge planner can look a program up through CARF’s Find a Provider tool using the ASAM Level of Care 3.7 filter. Both organizations confine the certification to those three residential levels and say nothing about withdrawal management, so a III.2-D social detox unit sits outside it. That limit is our reading of how both organizations describe the program.

    A rule rewrite is coming but is not law yet. HHS posted a draft replacement for Article 75-09.1 in 2024, and its draft rules page now gives an anticipated effective date of “July 1, 2027, pending completion of the formal rulemaking process and required approvals.” Write policies to the current chapters and watch for the formal notice.

    No Certificate of Need, but a Daily Bed Report

    Chapter 23-17.2 of the Century Code, which once governed approval of hospital expansion, now carries a “[Repealed]” tag, and nothing resembling need review appears anywhere in chapter 23-16. Chapter 23-16 does freeze one kind of bed: nursing facility beds, between August 1, 2025 and July 31, 2029. Residential SUD beds aren’t part of that freeze. In our reading a new residential program needs no state approval of need.

    What a residential program does pick up is a reporting duty. N.D.C.C. 50-06-41.3, most recently amended and reenacted by Senate Bill 2113 (signed May 2, 2025), says “Public and private providers of residential or inpatient behavioral health services” “shall participate in and report daily” to HHS’s behavioral health bed management system. Assign someone to that report from opening day.

    Medication for Opioid Use Disorder in a North Dakota Residence

    The current general standards in 75-09.1-01 contain no clause we could find that requires a residential program to provide MOUD or keeps it from refusing an applicant already on a maintenance dose. The pending draft would change that. It says “A program shall allow the use of medications approved by the Food and Drug Administration,” including medications for opioid use disorder, but it remains a draft until HHS finishes rulemaking. We would write the policy to the draft’s standard now, since a program built that way won’t need to rework admissions in 2027.

    Methadone for addiction belongs to a different license. BHD is the state opioid treatment authority under 50-31-07, and 50-31-08 says “A separate license is required for each location at which an opioid treatment program is operated.” A residential program doesn’t become one. It signs a coordination agreement with a licensed OTP so a resident’s doses continue during the stay. Buprenorphine needs much less. DEA’s January 12, 2023 letter to registrants says “A DATA-Waiver registration is no longer required” and that buprenorphine prescriptions “only require a standard DEA registration number.” At Level III.7, where 75-09.1-04-02 already requires a physician’s services 24 hours a day, starting or continuing buprenorphine fits the staffing you have to carry anyway.

    Adding Ketamine to a North Dakota Residential Program

    We found no BHD guidance or 75-09.1 provision on ketamine. The licensing conclusions here are our interpretation of the rules cited. The nursing material is the Board of Nursing’s own January 2026 guidance, and the drug rules are federal and state statute.

    The licensing side is lighter than the staffing side. Under 75-09.1-01-02, a new application is required when ownership changes or when the program changes its level of care. A medication added to a resident’s medical care is neither, so in our reading it doesn’t reopen the license. Send BHD a short description of the protocol at dhsbhd@nd.gov anyway and keep the reply with your policy manual. The Ketalar label lists only anesthetic uses, so ketamine isn’t MOUD and adds nothing to the opioid medication access discussed above. We would screen first for residents whose depression or post-traumatic stress lingered once withdrawal was over and a standard antidepressant trial had not helped. A history of misusing dissociatives counts against a resident, and your physician sets the final criteria.

    The Nursing Board Draws a Tight Line

    The North Dakota Board of Nursing’s sedation and analgesia guidance, updated January 2026, says giving anesthetic agents “(e.g., Propofol, methohexital, ketamine, and etomidate)” “for analgesia/sedation is outside the scope of practice for nurses EXCEPT in the following situations.” The exceptions are narrow: a CRNA or anesthesiologist present, intubated and ventilated critical care patients, assisting with emergency intubation, and refractory symptoms at the end of life. The guidance applies the word “nurse” to RNs and to APRNs who aren’t CRNAs, and it carves LPNs out completely, calling this work “not within the scope of the LPN.” The guidance never discusses low-dose ketamine for depression. Whether a psychiatric dose counts as analgesia or sedation is the open question, and until the board answers it we would not build a residential protocol around an RN pushing IV ketamine with no anesthesia provider present. Ask the board in writing. A 3.7 program, with physician services around the clock and 24-hour skilled nursing under 75-09.1-04-02, is the residential setting closest to what the guidance contemplates.

    Registration, the PDMP and Spravato

    Ketamine’s federal classification, set by 21 CFR 1308.13(c)(7), is Schedule III, and DEA’s rule at 21 CFR 1301.12 requires “A separate registration” for “each principal place of business or professional practice,” so the residence needs a registration at its own address if the drug is stored and given there. Check with the Board of Pharmacy before the first order on whether a state controlled substance registration is also needed. We couldn’t settle that from anything the board publishes. On the prescription drug monitoring program, N.D.C.C. 19-03.5-01 leaves a practitioner out of the “dispenser” definition “when the practitioner administers a controlled substance to a patient,” which in our reading means doses given in the building aren’t reported. Prescribing is another matter: an APRN with prescriptive authority must pull a PDMP report before writing a controlled substance prescription for a new client, under NDAC 54-05-03.1-10(4). For esketamine, the Spravato Medication Guide says it “can only be administered at healthcare settings certified in the SPRAVATO REMS program,” and that the provider “must monitor you for at least 2 hours after taking SPRAVATO.”

    Finishing the Series After Discharge

    Most residents leave before an induction series and its boosters are done. The rest happens at an outpatient ketamine practice, and North Dakota hasn’t settled who may own one. No North Dakota statute, rule or appellate ruling on corporate practice of medicine turned up in our search. The closest thing is a 1990 Attorney General letter to the Cass County State’s Attorney, which says “North Dakota public policy prohibits a corporation, other than a professional corporation,” “from employing physicians to provide medical care,” and then leaves any prosecution decision “to the state’s attorney in each and every case.” A letter like that doesn’t bind a court. Given it, our recommendation is the conservative build: a practice owned by a North Dakota licensed physician, with outside money held in a management company that bills the practice a flat fee unrelated to how many infusions it gives. Clinic ownership and staffing get their own treatment in the ketamine section of North Dakota Drug and Alcohol Outpatient Treatment Licensing.

    Referrals between the two need a lawyer’s eye. We found no North Dakota patient brokering statute, but BHD’s own rule already reaches the residence: 75-09.1-01-08(2) requires “a policy that prohibits fee splitting with other programs, agencies, entities, or individuals” “as consideration for referral of the client to be served.” Federally, 18 U.S.C. 220 covers a non-hospital setting providing residential treatment “pursuant to licensure or certification under State law,” and a violation can bring a fine up to $200,000, up to 10 years in prison, or both, “for each occurrence.”

    Staffing Each Residential Level

    Each level carries its own floor. At III.1, 75-09.1-02-02 says “A program shall provide staff twenty-four hours per day” and sets at least five hours a week of professionally directed treatment, including two support or group sessions. III.5 steps up to “Onsite, twenty-four hour per day clinical staffing by licensed counselors, other clinicians, and other allied health professionals such as counselor aides,” seven days a week (75-09.1-03-02). III.7 adds “twenty-four-hour skilled nursing care, daily onsite counseling services, and a physician’s services twenty-four hours per day seven days per week” (75-09.1-04-02). The phrase “medical director” doesn’t appear in any of those chapters. Across every level, substance use counseling and assessment fall to a licensed addiction counselor (LAC), and an LAC has to sit in on level-of-care and treatment planning meetings (75-09.1-01-15(6)).

    Counselor pay in North Dakota sits well above the national figure. BLS reports a statewide median of $68,630 for substance abuse, behavioral disorder, and mental health counselors (OEWS, May 2025), $9,280 above the national median of $59,350, with the state’s 25th and 75th percentiles at $55,450 and $77,320. Pay a clinical director and five counselors the state median and payroll reaches roughly $411,780 a year (6 x $68,630, our estimate), before overnight staff, nursing, physician coverage and benefits. You rarely have to fund that full figure on day one, because North Dakota’s counselor license has a built-in training stage. Under N.D.C.C. 43-45-04 the Board of Addiction Counseling Examiners keeps a register of clinical trainees and addiction counselor trainees, and an LAC candidate has to log 960 clinical training hours under NDAC 4.5-02.1-01, with trainee status allowed for up to twelve months plus a twelve-month extension at the supervisor’s request. A licensed clinical director supervising several trainees who are finishing those hours, at pay below a licensed counselor’s, typically trims clinical staffing costs somewhere between 40 and 60 percent, measured against filling every counselor seat with a fully licensed LAC. The LAC requirement for counseling and assessment still applies, so trainees work within the board’s supervision rules. A single RN can also direct several LPNs on routine medication passes, though the Board of Nursing’s guidance keeps LPNs away from sedation and analgesia work entirely. We fix the real roster once you know which levels you are licensing and how many beds each gets.

    Accreditation Entitles You to a License

    This section quotes NDAC 75-09.1-01-25 and 75-09.1-01-03 and BHD’s provider booklet directly.

    North Dakota’s accreditation rule is unusually strong. Under 75-09.1-01-25, “The department shall issue a license to a program that has a current accreditation of a nationally recognized body that reviews and certifies providers of drug and alcohol services.” The rule names no accreditor. In our reading CARF and The Joint Commission both fit the description, though BHD hasn’t published a list. At application and renewal you submit “the accreditation agency’s most recent review and certification.” BHD’s licensing provider booklet calls these “deemed status” providers and says they get a license “valid up to two years.”

    What the rule does not say is that accreditation replaces BHD’s own visits. Section 75-09.1-01-03 requires an onsite review before a provisional license becomes unrestricted and continued reviews “on at least a biennial basis,” with no exception for accredited programs, and N.D.C.C. 50-31-04 says the department “shall evaluate every licensed” program. Ask BHD how it schedules reviews for a deemed-status program before you plan around fewer visits.

    How to Submit Your BHD Residential Application

    The application is SFN 971, revision 2-2026. It must be notarized, and Section 4 is an attestation and disclosure covering fraud, investigations, exclusions and discipline. Attach your policies and procedures written to Article 75-09.1 (BHD may send them back for revisions), proof of registration with the North Dakota Secretary of State, the names of the licensed addiction counselors on staff, and the entity responsible for the program, per BHD’s licensing process page. Mail the packet to the Behavioral Health Division, 600 E Boulevard Ave, Dept. 325, Bismarck, ND 58505-0250, and email a copy to dhsbhd@nd.gov. Questions go to the same address or 701-328-8920.

    The fee comes from statute, not the form. N.D.C.C. 50-31-03.1 requires “a one hundred fifty dollar nonrefundable fee,” yet neither SFN 971 nor BHD’s licensing page mentions it. A second statute, N.D.C.C. 50-06-01.7, separately lets BHD set nonrefundable application fees “not to exceed three hundred dollars,” so ask BHD what amount it collects today and how it wants it paid before you mail anything. BHD says “An initial review of the application and policy manual may take up to 6 weeks.” A new program usually starts on a provisional license of up to one year, converts to an unrestricted license (two years at most) after an onsite review, and gets a written license report within 30 days of that review (75-09.1-01-03 and -04). Under 75-09.1-01-02, BHD may declare an application withdrawn if missing documents are still outstanding sixty days after it tells you the file is incomplete.

    What Holds Up North Dakota Residential Files

    The delay we expect most often is the policy manual. BHD reviews it against every applicable chapter, and a manual copied from another state usually lacks the level-specific hour and staffing rules North Dakota writes into each chapter. A second snag is the premises safety certification under 50-31-04, which depends on a local inspector’s calendar rather than BHD’s. A third is a plan that mixes a 3.7 unit with hospital space, since the 2023 exemption applies only when the program is independent from a medical hospital.

    Frequently Asked Questions

    Does a freestanding ASAM 3.7 program in North Dakota need a hospital license?

    No. Since HB 1050 (2023), N.D.C.C. 23-16-01 says Level 3.7 substance use treatment programs licensed by HHS and independent from a medical hospital do not need a hospital license. The program is licensed by the HHS Behavioral Health Division under chapter 50-31 and NDAC 75-09.1-04. A 3.7 unit operated inside a hospital stays under hospital licensing.

    How long does it take to license a residential SUD program in North Dakota?

    BHD says its initial review of the application and policy manual may take up to 6 weeks. Our planning estimate for a residential program is 4 to 8 months overall, because staffing, the premises safety certification and the onsite review that converts a provisional license all take time. There is no certificate of need step.

    Does CARF or Joint Commission accreditation help with a North Dakota SUD license?

    Yes. NDAC 75-09.1-01-25 says HHS shall issue a license to a program with current accreditation from a nationally recognized body, and BHD calls these deemed status licenses valid up to two years. The rules do not say accreditation replaces BHD onsite reviews, so ask BHD how it schedules them.

    Weighing a freestanding 3.7 build against a hospital-based unit in North Dakota? Send us your plan.

    Sources

  • Sample Medication Destruction Policy Checklist

    Sample Medication Destruction Policy Checklist

    By A. Ant, CADC-II, Licensing & Accreditation Expert

    A medication sample left in a locked cabinet after its expiration date can become more than a housekeeping issue. It raises immediate questions: Who owned the inventory? Was the medication still available for use? Is there a traceable record of removal and destruction? A sample medication destruction policy must give leadership a defensible governance structure for answering those questions without relying on staff memory or informal practice.

    This is not a document to copy from another facility and file away. Medication samples create distinct accountability issues because they may enter the organization outside routine purchasing channels, move between storage areas, and remain on hand after a prescriber changes practice or leaves the organization. For behavioral health operators, inconsistent medication-sample controls can expose gaps in inventory management, staff authority, documentation, and environmental safety.

    This readiness guide is based on Joint Commission Medication Management standard MM.01.01.01, Element of Performance 1, which addresses the organization’s written plan for managing medications. Confirm the currently applicable accreditation requirements and all state-specific rules before approving or revising any policy.

    Why a sample medication destruction policy receives scrutiny

    Destruction is the final link in a medication-control chain. A reviewer may begin with one expired sample, then test whether the organization can account for how it was received, secured, monitored, removed from usable stock, and documented through final disposition. If any part of that chain is unclear, the issue may be viewed as a system failure rather than an isolated oversight.

    A policy should distinguish between samples and other medication categories when the organization’s operations require it. The destruction pathway for routine prescription samples may differ from the pathway for controlled substances, hazardous medications, recalled products, investigational products, or medications supplied under a separate vendor arrangement. One generic process for every item can create risk when different legal, contractual, or safety obligations apply.

    The policy also needs to reflect the actual program model. A single-site outpatient program with limited samples has different inventory exposure than a multi-location behavioral health operator using several medication storage areas. The governing principle remains the same: leadership must be able to identify the medication, its status, the responsible personnel, and the records that support disposition.

    Sample medication destruction policy readiness checklist

    Use this checklist to identify whether the required governance components are present. It is not policy language and is not a substitute for a facility-specific review.

    • Scope and definitions: Does the policy define medication samples and identify the locations, programs, and personnel covered?
    • Authority and responsibility: Does it identify the roles authorized to identify, remove, witness, document, supervise, and review sample medication destruction activities?
    • Inventory accountability: Does it connect sample receipt, storage, expiration monitoring, removal, and final disposition to an accountable inventory record?
    • Medication classification: Does it direct staff to use the appropriate process for controlled, hazardous, recalled, or otherwise specially regulated products when applicable?
    • Segregation from usable stock: Does it require medication awaiting destruction to be clearly separated from medication available for administration or dispensing?
    • Secure interim storage: Does it address how items are secured between identification and final destruction or transfer?
    • Destruction or transfer pathway: Does it identify the approved disposition method and the circumstances that require a different pathway?
    • Witness and verification controls: Does it specify when independent verification or witnessing is required under applicable requirements?
    • Documentation elements: Does it require records that establish what was removed, why, when, by whom, and through which approved disposition process?
    • Vendor or third-party records: If a third party is used, does the organization retain evidence of transfer, receipt, and final disposition as applicable?
    • Discrepancy escalation: Does it identify where unexplained inventory variances, missing samples, incomplete records, or unauthorized access are reported?
    • Oversight and review: Does it assign leadership responsibility for periodic review of sample inventory and destruction documentation?
    • Training and competency: Does it identify which staff require training based on their role in the medication-management process?
    • Record retention: Does it identify the retention standard and where records are maintained for timely retrieval?

    A “no” or “not sure” answer does not automatically mean a deficiency exists. It does mean the organization has a question that should be resolved before a surveyor, regulator, payer, partner, or internal investigator asks it first.

    Fillable policy-development framework

    A policy framework should establish the decision structure, not offer staff vague instructions. Use the following fields to determine whether your organization has enough information to develop a facility-specific document.

    Document control fields

    Policy title: ____________________ Policy owner: ____________________ Approving authority: ____________________ Effective date: ____________________ Review cycle: ____________________ Related policies and forms: ____________________

    Applicability fields

    Programs and locations covered: ____________________ Medication sample types included: ____________________ Excluded medication categories and governing process: ____________________ Applicable state, accreditation, organizational, and contractual requirements: ____________________

    Accountability fields

    Executive owner: ____________________ Clinical or pharmacy oversight role: ____________________ Authorized personnel roles: ____________________ Required witness or verifier role, if applicable: ____________________ Leadership review responsibility: ____________________

    Process-control fields

    Trigger for removal from usable inventory: ____________________ Interim segregation and storage location: ____________________ Approved destruction or transfer method: ____________________ External vendor or authorized recipient, if applicable: ____________________ Required documentation record: ____________________ Discrepancy reporting pathway: ____________________

    Monitoring fields

    Inventory review frequency: ____________________ Documentation audit frequency: ____________________ Responsible reviewer: ____________________ Escalation threshold: ____________________ Corrective-action tracking record: ____________________

    What records should leadership be able to produce?

    The policy itself is only one part of readiness. During an audit, leadership should be able to retrieve evidence that the policy is operating as intended. The appropriate record set depends on the organization’s services, medication categories, state requirements, and whether a third party performs any disposition activity.

    At a minimum, operators should be prepared to evaluate whether their records connect the sample medication to its lifecycle. That may include a sample receipt or inventory record, an expiration-monitoring record, a removal or quarantine record, a disposition record, witness documentation when required, and evidence of third-party transfer or destruction when used. The records must tell the same story. A completed disposition log cannot compensate for inventory records that never show the medication was on hand.

    Electronic systems can improve retrieval, but they do not eliminate accountability. A digital log with missing fields, shared credentials, unclear approval authority, or no review trail may create the same exposure as a paper form that is incomplete or unavailable.

    Common risk signals for operators

    The clearest warning signs are usually operational, not theoretical. Samples stored alongside usable stock without a marked status, expired items identified only during a walkthrough, and destruction records completed days after the activity all suggest that controls may not be working as designed.

    Another concern is role confusion. If staff cannot explain who may remove samples, who verifies disposition, or who reviews discrepancies, the organization has not established reliable accountability. A policy should match the staff and oversight resources actually available at each site. Assigning responsibilities to a role that does not exist at a satellite location is not an effective control.

    Finally, do not treat a sample-medication process as isolated from the rest of medication management. It should align with inventory practices, storage controls, incident reporting, documentation retention, staff education, and leadership oversight. Misalignment between related documents is a frequent source of preventable findings.

    If your checklist reveals unclear ownership, incomplete records, or a process that staff cannot consistently explain, contact Continued Compliance for a focused policy and operational-readiness review. Our work is built around practical execution and regulatory success, not generic templates.

    The strongest destruction policy is not the longest one. It is the one your organization can support with clear authority, consistent records, and real evidence every time a sample leaves inventory.

    This article was reviewed and approved for accuracy by the compliance expert cited above before publication. The first draft of this article was AI-assisted from facts and context given to it by the author, and it was reviewed and edited by that expert before it was published. Due to the complex nature of compliance with thousands of rules and regulations automation is used by us to ensure the most accurate information is displayed. This content is provided for general informational purposes only and should not be construed as medical, clinical, legal, financial, tax, accounting, insurance, licensing, accreditation, regulatory, billing, employment, or compliance advice. Requirements change frequently. Consult qualified professionals or contact Continued Compliance, Inc. for guidance specific to your situation.

  • Kentucky License Reinstatement

    Kentucky License Reinstatement

    Author: A. Ant, CADC-II, Licensing & Accreditation Expert

    Disclaimer: This content is provided for general informational purposes only and should not be construed as legal, regulatory, or licensing advice. Requirements change frequently. Consult qualified professionals for guidance specific to your situation.

    When Kentucky suspends an addiction treatment license on an emergency basis, the licensee has five calendar days to ask for a hearing, and the cabinet must hold it within ten working days. A mental health license on the other side of the same cabinet works on a different clock, with an urgent suspension hearing set no sooner than twenty days after the notice is delivered. That split follows the agency split Kentucky created on April 5, 2023, when licensing for alcohol and other drug entities (AODEs) moved to the Department for Behavioral Health, Developmental and Intellectual Disabilities (DBHDID) while behavioral health services organizations (BHSOs) stayed with the CHFS Office of Inspector General (OIG). Neither framework has a reinstatement procedure. A license that ends is replaced, if at all, by a new application.

    Reading the Rule Version Behind a Citation

    Before answering any Kentucky finding, check what the cited regulation actually says today, and look closely at its history line. An entry such as “Crt eff. 7-1-2026” on 908 KAR 1:370 or “Crt eff. 9-24-2026” on 902 KAR 20:430 is not an amendment. Under KRS 13A.3104, added by 2021 Ky. Acts ch. 125, an agency files a certification letter saying a regulation “Shall remain in effect without amendment because it is in compliance with current governing law,” and the compiler updates the history line to show it. The AODE rule’s last text change was a 2020 technical amendment. An amendment to 908 KAR 1:370 filed on July 13, 2026 to implement HB 470 was still pending on October 14, 2026, so a surveyor citing new peer support language before it takes effect is a fair thing to question.

    How DBHDID Enforces the AODE Rules

    The steps in this section come from KRS 222.231 and 908 KAR 1:370, quoted where the wording matters.

    Every AODE gets an unannounced survey each year under 908 KAR 1:370, even though KRS 222.231 requires the cabinet to visit accredited agencies no less often than every two years. Violations arrive as a written notice. The program then has “ten (10) calendar days of the notice” to submit “a written plan for the correction of the regulatory violation,” and if DBHDID rejects it, another ten calendar days to file an amended plan. The rule contains no civil money penalty schedule and no conditional or probationary license, so the step after an unacceptable plan is denial or revocation.

    908 KAR 1:370 lists when “The cabinet shall deny or revoke a license.” The grounds include substantial noncompliance, no acceptable plan of correction, failure to renew, refusing the cabinet access, prior enforcement tied to someone with a significant financial interest, a history of fraud, and misrepresentation. A denial or revocation “shall become final and conclusive thirty (30) days after notice is given,” “unless the applicant or licensee submits a written request for a hearing within the thirty (30) day period,” and the hearing runs under KRS Chapter 13B.

    Emergency suspension is reserved for immediate danger. Under KRS 222.231, the licensee can request an emergency hearing within 5 calendar days of receiving the notice, the hearing happens within 10 working days of the request, and a decision follows within 5 working days. The licensing rule narrows what gets argued: under 908 KAR 1:370, “The sole issue of the hearing shall be whether there is immediate danger.” The statute sends appeals to Franklin Circuit Court. Running a program after a license is gone exposes the operator to the penalties in KRS 222.990(2), which 908 KAR 1:370 applies to anyone operating without the license KRS 222.231 requires, with a fine of up to $500 for a first offense and up to $1,000, up to two years of imprisonment, or both for later ones.

    The OIG Track for Mental Health Licenses

    A BHSO, residential crisis stabilization unit or psychiatric hospital answers to OIG, and the general OIG licensing rule, 902 KAR 20:008, gives a facility “ten (10) days of the notice” to submit its plan of correction. For BHSOs, 902 KAR 20:430 allows 30 days from the notice to file a written hearing request, and a denial or revocation that goes unchallenged in that window becomes final. An urgent suspension hearing is set “no sooner than twenty (20) days from the delivery of the notice,” and “Within five (5) working days of completion of the hearing, the cabinet’s hearing officer shall render a written decision.”

    One BHSO risk has no AODE counterpart. The clock starts at initial licensure: a BHSO has twelve months to become accredited by the Joint Commission, CARF, the Council on Accreditation or some other nationally recognized accreditor. It can ask once for more time, but that request has to reach OIG at least 60 days before the yearly renewal date. Proof of accreditation then goes to OIG at every renewal. A BHSO that never gets accredited, or loses it, faces revocation. Residential crisis units carry the same one-year accreditation requirement. The mental health guides, Kentucky Mental Health Outpatient Licensing and Kentucky Mental Health Inpatient Licensing, cover those licenses in full.

    StepAODE (DBHDID)BHSO (OIG)
    Plan of correction10 calendar days, then 10 more for an amended plan (908 KAR 1:370)10 days (902 KAR 20:008)
    Hearing request after denial or revocation noticeWithin 30 days, or the action becomes finalWithin 30 days, or the action becomes final
    Emergency or urgent suspension hearingRequest within 5 calendar days, hearing within 10 working daysNo sooner than 20 days after notice is delivered
    Decision after the hearingWithin 5 working daysWithin 5 working days
    Accreditation as a license conditionNo, except partial hospitalizationYes, within one year of initial licensure

    Putting Together a Response Kentucky Will Accept

    A plan of correction due in ten days tempts people to write promises. Reviewers respond better to evidence: the revised policy already adopted, a dated training roster with competency checks, and an audit that shows the fix holding a month later. If a finding involves an incident, look at 908 KAR 1:370’s incident provision as well. It requires AODEs to keep an incident file and to notify the cabinet when KRS 620.030 or KRS 209.030 requires an abuse or neglect report, and those statutes call for reporting “immediately.” The licensing rule itself sets no separate deadline.

    Staffing citations are likely to rise in 2027. HB 470 (2026 Ky. Acts ch. 80) ends the grace period on January 1, 2027. From that date an AODE or BHSO can keep an alcohol and drug peer support specialist on payroll only if that person is registered under KRS 309.0831, and the temporary peer credential no longer exists. Pull a registration printout for every peer on staff before that date and keep it in the personnel file.

    Starting Over After a Lapse or Revocation

    An AODE license runs one year under KRS 222.231 and renews through “Annual Re-licensure/Change applications” in DBHDID’s online AODE system on Kentucky Online Gateway. Failing to renew is itself a ground for denial or revocation. Since we found no reinstatement process in the statute or the rule, our reading is that a program that lets its license go, or loses it, files a fresh initial application with the $500 fee and goes through the pre-licensure inspection again. It cannot admit clients in the meantime.

    We found no waiting period after revocation in the AODE rule, but it does look back. 908 KAR 1:370 keeps a person who held a significant financial interest in a facility revoked or denied for risk of death or serious harm from acquiring a significant financial interest in an AODE “within the preceding seven (7) years.” Investors with that kind of history should be disclosed and reviewed with counsel before a new application is filed. For questions before refiling, contact the AODE Help Desk at 502-564-0104 Option 4 or chfs.aodehelpdesk@ky.gov. A former BHSO goes back to OIG’s Division of Health Care at 275 East Main Street, 5E-A, Frankfort, KY 40621 (502-564-7963). Our reading of 902 KAR 20:008 is that a returning BHSO would start over on a provisional license, with an unannounced inspection within three months. How every Kentucky license type fits together is mapped in Kentucky Behavioral Health Licensing.

    Frequently Asked Questions

    Can a revoked Kentucky AODE license be reinstated?

    Not through a reinstatement process. KRS 222.231 and 908 KAR 1:370 contain none, so in our reading the program files a new initial application, pays the $500 fee and is inspected again before it can admit clients.

    How fast is the hearing after an emergency suspension of a Kentucky AODE?

    The licensee can request an emergency hearing within 5 calendar days, the hearing must be held within 10 working days, and the decision is due within 5 working days after it. The only question at that hearing is whether there is immediate danger.

    What happens if a Kentucky BHSO is not accredited within a year?

    Unless an extension was granted, 902 KAR 20:430 has the cabinet revoke the license. The organization gets a year from initial licensure to become accredited and may request a one-time extension, which has to be filed no later than 60 days before the renewal date. Losing accreditation later carries the same result.

    Facing a ten-day plan of correction deadline in Kentucky? Contact us.

    Sources

  • Kentucky Mental Health Outpatient Licensing

    Kentucky Mental Health Outpatient Licensing

    Author: A. Ant, CADC-II, Licensing & Accreditation Expert

    Disclaimer: This content is provided for general informational purposes only and should not be construed as legal, regulatory, or licensing advice. Requirements change frequently. Consult qualified professionals for guidance specific to your situation.

    A Kentucky outpatient mental health license comes with an expiration clock that has nothing to do with the renewal date. Under 902 KAR 20:430, a behavioral health services organization (BHSO) must “become accredited within one (1) year” of its initial license by The Joint Commission, CARF, COA or another national accreditor, and a BHSO that misses that window, or later loses its accreditation, faces revocation. The license comes from the Cabinet for Health and Family Services’ Office of Inspector General (OIG), Division of Health Care, on a paper form, and it covers mental health care with substance use treatment allowed only as a secondary diagnosis.

    BHSO, AODE or Private Office

    Columns one and two restate 902 KAR 20:430 and 908 KAR 1:374. Column three applies KRS 216B.020 and is our reading.

    ItemBHSO (OIG)Outpatient AODE (DBHDID)Practitioner’s private office
    Who it fitsMental health as the primary diagnosis, SUD only as secondarySubstance use disorder as the main reason for careLicensed clinicians practicing in their own office
    Rule902 KAR 20:430908 KAR 1:370 and 1:374Outside KRS 216B under 216B.020(2)(a)
    Fee$750 initial, $500 renewal, $250 per extension location$500, plus $80 per outpatient extension siteNone from OIG
    AccreditationRequired within one year, proof every renewalNot required, except partial hospitalizationNot required
    FilingPaper form to OIG in FrankfortOnline AODE system on the Kentucky Online GatewayNot applicable

    KRS 216B.020(2)(a) says the health facility chapter does not apply to “Private offices and clinics of physicians, dentists, and other practitioners of the healing arts,” except offices that meet KRS 216B.015(5) or are ambulatory surgical centers. Because the BHSO rule rests on KRS 216B.042, our reading is that a practice built around licensed clinicians seeing their own clients may not need a BHSO license at all. We found no OIG statement drawing that line, and 908 KAR 1:370 separately exempts a practitioner’s private office from AODE licensure, so put the question to OIG in writing before you decide the practice sits outside licensure.

    What a BHSO License Covers

    The service list and application details below come from OIG’s own application form and the rule text.

    A BHSO may offer only the services 902 KAR 20:430 lists, and the OIG application asks you to check each one: screening, assessment, psychological testing, crisis intervention, mobile crisis, day treatment, peer support, intensive outpatient, individual, group, family and collateral therapy, service planning, SBIRT, assertive community treatment, comprehensive community support, therapeutic rehabilitation, targeted case management and partial hospitalization. The rule defines a BHSO as an entity licensed “to provide behavioral health services as described in Section 5,” so anything outside that list sits outside the license.

    Partial hospitalization carries an extra step that is easy to miss. KRS 216B.020(1) exempts “outpatient behavioral health treatment, but not including partial hospitalization programs,” from Certificate of Need. By our reading, a BHSO that wants to add partial hospitalization needs a CON first, while its other outpatient services do not.

    Filing the Application

    The form is OIG’s Application for License to Operate a Behavioral Health Services Organization (October 2019 edition). It goes to the Office of Inspector General, Division of Health Care, 275 East Main Street, 5E-A, Frankfort, KY 40621, with the $750 fee. The packet needs the Fire Marshal’s approval for each service location, current if dated within the last 12 months, and the names of everyone holding a 25 percent or larger ownership interest. Change fees are $100 to move to a new location, $25 for a name change and $750 for a change of ownership. For questions before filing, the Division of Health Care’s central office lists 502-564-7963.

    What happens after filing is our reading of how the BHSO rule points back to OIG’s general license regulation, 902 KAR 20:008. That rule issues a provisional license, sends surveyors unannounced “Within three (3) months from the effective date of a provisional license,” and allows ten days to answer a deficiency notice with a plan of correction. The BHSO rule’s own history line ends “Crt eff. 9-24-2026,” which records a certification that the regulation remains in effect, not a rewrite.

    Substance Use Care Inside a Mental Health License

    The BHSO rule allows substance use treatment only where “The mental health disorder is the primary diagnosis and SUD is the secondary diagnosis.” When a practice wants to serve people whose main problem is addiction, the license changes and so does the office. Since April 5, 2023, alcohol and other drug entities have been licensed by the Department for Behavioral Health, Developmental and Intellectual Disabilities rather than OIG, through an online system, under 908 KAR 1:370 and 1:374. The full outpatient process is in Kentucky Drug and Alcohol Outpatient Treatment Licensing.

    Peer staff rules shift on January 1, 2027. HB 470 (2026 Ky. Acts chapter 80, signed April 10, 2026) amended KRS 222.233 so that from that date behavioral health service organizations, like AODEs, may “only employ an alcohol and drug peer support specialist who is registered under KRS 309.0831.” Check each alcohol and drug peer’s registration status before the new year arrives.

    Can a Kentucky Outpatient Mental Health Practice Offer Ketamine?

    Kentucky’s BHSO rule does not mention ketamine. The conclusions below about the license are our reading. The nursing, prescribing and federal points cite their sources directly.

    Not as a BHSO service, in our reading. The 19 services in 902 KAR 20:430 are counseling, crisis and support services, and medication infusion is not one of them. A BHSO that wants ketamine on site would be adding something its license does not describe, so ask OIG before scheduling the first patient. A physician or APRN practice operating as a private office under KRS 216B.020(2)(a) is in a different position, because the facility chapter does not reach it, which leaves the obligations on the prescribers themselves.

    Those obligations start federally. 21 CFR 1308.13(c)(7) lists ketamine in Schedule III, and 21 CFR 1301.11 requires a DEA registration of every person who “dispenses” a controlled substance unless exempted by law. Kentucky’s monitoring system is KASPER. Its CHFS page tells dispensing practitioners to report “within one business day of administering” or dispensing a controlled substance and asks for “administered or dispensed” information, while 902 KAR 55:110 puts the deadline at close of business on the business day after dispensing. We read that as reaching doses given on site, and KASPER can confirm the mechanics for a particular setup.

    Nurse practitioners face a Kentucky-specific prescribing step. Under KRS 314.042, an APRN needs a controlled substance collaborative agreement (CAPA-CS) with a physician “before an advanced practice registered nurse engages in the prescribing of Schedules II through V controlled substances.” The statute offers a way out after four years. An APRN who has “Completed four (4) years of prescribing authority for controlled substances with a CAPA-CS” and keeps both a DEA registration and a master KASPER account can be exempted, though prescribing without the agreement waits until the Board of Nursing says so in writing.

    For RNs running infusions, the Board of Nursing’s Advisory Opinion Statement #43 places subanesthetic ketamine for psychiatric disorders within RN scope for nurses who are trained and competent. The RN works under a qualified healthcare provider’s direct supervision and monitors the patient continuously, and an ACLS-certified provider stays on the premises through discharge. Its narrative bars LPNs from giving it, though its summary grid reads otherwise, and we would go with the narrative. Spravato has its own federal gate: the FDA label says it “can only be administered at healthcare settings certified in the SPRAVATO REMS program,” with at least two hours of monitoring after each dose.

    Ownership comes next, and here Kentucky leans restrictive. No statute or rule we found speaks to it directly, but the state’s top court ruled in Kendall v. Beiling (1943) that a corporation employing a licensed optometrist was unlawfully practicing optometry, and it remarked that “there is scarcely any judicial dissent from the proposition that a corporation cannot lawfully engage in the practice of law or of medicine.” That holding dealt with eye examinations, not psychiatry, so applying it to a counseling group or investor that wants a stake in a prescribing practice is interpretation on our part. We would keep the medical practice in a physician’s hands, put investors in a management services company paid under a written agreement, and have a Kentucky health care attorney sign off before any ownership interest changes hands. The ketamine section of Kentucky Drug and Alcohol Outpatient Treatment Licensing walks through how a stand-alone clinic is usually organized.

    Staffing a Kentucky BHSO

    902 KAR 20:430 asks for an executive director holding either a master’s in business administration or a human services field plus two years of supervisory experience, or a bachelor’s degree backed by two years in a human services program and two more supervising in one. The program director has to be an LCSW, LPCC, LMFT, APRN, licensed psychological practitioner, psychologist, physician or psychiatrist, or else a licensed professional art therapist or licensed behavior analyst. Criminal record checks happen at hire, and every year a random sample of at least a quarter of the staff goes through criminal record and registry checks again. BLS sets Kentucky’s median for substance abuse, behavioral disorder and mental health counselors at $54,190, with the middle half paid between $41,730 and $72,590 (BLS OEWS, May 2025), about $5,160 short of the $59,350 median nationwide. By our arithmetic, five clinicians at the state median total $270,950 annually before the directors and benefits. A BHSO’s own rule lets supervised associates carry a large share of its therapy hours. That rule’s category of “behavioral health professional under clinical supervision” reaches licensed psychological associates, marriage and family therapist associates, certified social workers and licensed professional counselor associates. Pairing a licensed program director with associates who are still building their hours, and paying associate rates while they do, is how many Kentucky BHSOs commonly land with a therapy payroll 40 to 60 percent lighter than a fully licensed staff would produce. If medication management is on the service list, letting one RN oversee LPNs keeps nursing costs below an RN-only staff. Your service list and caseload determine the real numbers.

    Where Kentucky Outpatient Mental Health Plans Go Off Track

    The accreditation year is the most common surprise, because owners budget for the license and forget the survey that must follow within twelve months. Next comes the diagnosis rule. A practice that drifts toward addiction-primary clients is operating outside its BHSO license and needs an AODE from a different department. And partial hospitalization added late in a business plan can stall on a Certificate of Need nobody scheduled.

    Frequently Asked Questions

    What license does an outpatient mental health program need in Kentucky?

    A behavioral health services organization license from OIG’s Division of Health Care under 902 KAR 20:430. The initial fee is $750, renewal is $500, and the BHSO must become accredited within one year. Private offices of licensed practitioners fall outside the health facility chapter under KRS 216B.020, which by our reading may cover some therapy practices, so confirm your model with OIG.

    Does a Kentucky BHSO have to be accredited?

    Yes. 902 KAR 20:430 requires accreditation by The Joint Commission, CARF, COA or another national accrediting body within one year of initial licensure. A single extension can be had by asking 60 or more days ahead of the annual renewal, proof goes in with each renewal, and a BHSO that loses accreditation faces revocation.

    Can a Kentucky BHSO treat substance use disorders?

    Only when mental illness is the primary diagnosis and the substance use disorder is secondary. A program treating addiction as the main condition needs an alcohol and other drug entity license from DBHDID, filed online, instead.

    Trying to decide between a BHSO license and a private practice structure in Kentucky? Send us the details.

    Sources

    • 902 KAR 20:430 (behavioral health services organizations): 902 KAR 20:430 (checked October 14, 2026)
    • OIG, BHSO license application (October 2019): BHSO application (PDF) (checked October 14, 2026)
    • CHFS OIG, Division of Health Care applications (AODE transfer to DBHDID): Applications (checked October 14, 2026)
    • CHFS OIG, Division of Health Care contact list: Contact list (PDF) (checked October 14, 2026)
    • 902 KAR 20:008 (OIG license procedures): 902 KAR 20:008 (checked October 14, 2026)
    • KRS 216B.020 (private office exclusion, CON exemptions): KRS 216B.020 (checked October 14, 2026)
    • 908 KAR 1:370 (AODE fees and exemptions): 908 KAR 1:370 (PDF) (checked October 14, 2026)
    • 908 KAR 1:374 (outpatient AODEs): 908 KAR 1:374 (checked October 14, 2026)
    • DBHDID, AODE online system flyer: AODE Online System (PDF) (checked October 14, 2026)
    • 2021 Ky. Acts ch. 125 (KRS 13A.3104 certification letters): Acts ch. 125 (PDF) (checked October 14, 2026)
    • 2026 HB 470, Acts ch. 80 (peer support specialists): Acts ch. 80 (PDF) (checked October 14, 2026)
    • KRS 314.042 (APRN prescribing, CAPA-CS): KRS 314.042 (checked October 14, 2026)
    • Kentucky Board of Nursing, Advisory Opinion Statement #43: Subanesthetic dosing ketamine (PDF) (checked October 14, 2026)
    • CHFS OIG, KASPER: KASPER (checked October 14, 2026)
    • 902 KAR 55:110 (KASPER reporting): 902 KAR 55:110 (checked October 14, 2026)
    • 21 CFR 1308.13(c)(7), via Cornell LII: Ketamine in Schedule III (checked October 14, 2026)
    • 21 CFR 1301.11, via Cornell LII: DEA registration requirement (checked October 14, 2026)
    • U.S. FDA, Spravato prescribing information and Medication Guide: Spravato label (PDF) (checked October 14, 2026)
    • Kentucky Court of Appeals opinion, Kendall v. Beiling (Oct. 1, 1943), 295 Ky. 782: Read on CourtListener (checked October 14, 2026)
    • U.S. Bureau of Labor Statistics, OEWS May 2025, Kentucky, SOC 21-1018: Kentucky OEWS and national estimates (checked October 14, 2026)
  • Kentucky Mental Health Inpatient Licensing

    Kentucky Mental Health Inpatient Licensing

    Author: A. Ant, CADC-II, Licensing & Accreditation Expert

    Disclaimer: This content is provided for general informational purposes only and should not be construed as legal, regulatory, or licensing advice. Requirements change frequently. Consult qualified professionals for guidance specific to your situation.

    Before anyone in Kentucky licenses a psychiatric bed, a formula decides whether that bed may exist. The 2025 State Health Plan update, which 900 KAR 5:020 has incorporated since January 22, 2026, says licensed and approved adult and geriatric psychiatric beds in a planning area “shall not exceed 0.2 beds per 1,000 geographic adult and geriatric population for the plan year.” Psychiatric beds need a Certificate of Need, so that ratio, together with the plan’s occupancy targets, shapes every hospital project. The one 24-hour mental health setting that skips CON is the residential crisis stabilization unit, which the Office of Inspector General (OIG) licenses under its own rule and which has to be accredited within a year.

    Kentucky’s 24-Hour Mental Health Licenses Side by Side

    Each cell restates the regulation or statute named in it, as published by the Kentucky Legislative Research Commission.

    ItemPsychiatric hospitalResidential crisis stabilization unit
    Rule902 KAR 20:180 (operations) and 902 KAR 20:170 (facility specifications)902 KAR 20:440
    Licensing officeOIG, Division of Health CareOIG, Division of Health Care
    Certificate of NeedRequired (KRS 216B.061)Exempt (KRS 216B.020(1))
    SizeSet by the CON and the State Health Plan’s 0.2 per 1,000 ceilingNo more than 16 clients needing overnight stays, community-based and “not part of an inpatient unit”
    State license fee$750 plus $25 per bed at 25 beds or fewer, $1,000 plus $25 per bed at 26 or more, initial and annual (902 KAR 20:008)$750 initial, $500 renewal filed at least 60 days ahead
    AccreditationJoint Commission or CMS-approved accreditation accepted as evidence of compliance (KRS 216B.185)Required within one year of licensure
    Clinical coverageRN on duty 24 hours a day, physician available 24 hours at least on callPsychiatrist access around the clock, telehealth allowed, direct-care ratio of 1 to 4 awake and 1 to 6 asleep

    We looked through the 902 KAR 20 chapter listing for a license aimed at longer-term adult residential mental health treatment outside a hospital and did not find one. Our reading is that an adult program wanting round-the-clock mental health care chooses between these two settings. Psychiatric residential treatment facilities exist too, but the State Health Plan describes them as serving young people no older than 21, so they fall outside this guide.

    Getting Psychiatric Beds Through Certificate of Need

    Our reading of how the CON statute, the exemptions and the State Health Plan fit together. Quotes come from the official text.

    KRS 216B.061 says no one may “Establish a health facility,” make “a substantial change in the bed capacity of a health facility,” or make “a substantial change in a health service” without first obtaining a CON, and KRS 216B.015 lists psychiatric hospitals inside its definition of a health facility. The exemption list in KRS 216B.020(1) helps crisis units and outpatient care, but it expressly leaves out “licensed psychiatric inpatient beds.” So every new psychiatric hospital, and every added psychiatric bed at an existing one, is a CON filing first.

    Inside the review, the State Health Plan does most of the work. Besides the 0.2 per 1,000 ceiling, the plan sets target occupancy that climbs with size, from 60 percent for programs of 1 to 50 beds to 75 percent at 201 beds and above. The CON filing itself is priced by 900 KAR 6:020. A project spending nothing or no more than $200,000 pays $1,000, a larger one pays half a percent of its capital budget until that budget passes $5 million, and anything bigger pays a flat $25,000.

    There is also a Kentucky rule aimed at hospitals that drift into addiction care. Under 902 KAR 20:180, a psychiatric hospital whose chemical dependency census climbs past 10 percent of its licensed beds must “Apply for a certificate of need in order to convert the necessary number of beds to chemical dependency services.” A hospital planning a dual-diagnosis unit should run that number before admissions reach it. Chemical dependency beds have their own ceiling in the plan, 11.4 per 100,000 residents, so conversion is not automatic.

    Licensing the Hospital With OIG

    The license application is OIG’s Hospital Application, which covers every hospital type. OIG’s general license rule, 902 KAR 20:008, issues a provisional license first, schedules an unannounced inspection “Within three (3) months from the effective date of a provisional license,” and gives a facility ten days from a deficiency notice to submit a plan of correction. The license runs one year from its effective date.

    Accreditation changes the inspection cycle for hospitals. KRS 216B.185 says “The Office of the Inspector General shall accept accreditation by the Joint Commission” and other CMS-approved accreditors as evidence of compliance, and that “An annual on-site licensing inspection of a hospital shall not be conducted” when the accreditation reports are submitted. In our experience, owners who plan Joint Commission survey timing alongside opening avoid running two inspection tracks in the first year.

    A psychiatric hospital can also run medically managed intensive inpatient withdrawal management under 902 KAR 20:111, which allows that service only in a hospital, including a psychiatric hospital, or a 902 KAR 20:160 chemical dependency program. That rule’s history line ends “Crt eff. 5-14-2026,” a certification that it stays in force, not new text. It still says a facility managing acute opioid withdrawal needs at least one physician “with a waiver” under 21 U.S.C. 823(g)(2) to prescribe opioid use disorder drugs. DEA’s January 2023 letter to registrants says that waiver is no longer required for buprenorphine, so we read the rule’s wording as dated and would ask OIG how surveyors apply it.

    Running a Residential Crisis Stabilization Unit

    902 KAR 20:440 describes the unit as a “community-based facility that is not part of an inpatient unit,” and it may house no more than 16 clients overnight. A psychiatrist must be reachable at all hours, by telehealth if need be, and direct-care staffing runs one to four while residents are awake and one to six while they sleep. Fees are $750 to apply and $500 to renew, with renewal due at least 60 days before expiration. The unit has one year from licensure to become accredited by The Joint Commission, CARF, COA or another national accreditor. Written policies must cover reporting abuse, neglect and exploitation under KRS Chapters 209 and 620. OIG lists a separate crisis stabilization unit application.

    Crisis units are also exempt from the AODE license under 908 KAR 1:370, so a unit treating someone in crisis with a co-occurring substance use problem does not need a second license from the Department for Behavioral Health, Developmental and Intellectual Disabilities.

    Ketamine on a Kentucky Psychiatric Unit or in a Crisis Unit

    The Kentucky licensing rules for these two settings do not mention ketamine. Which setting can start a course of treatment is our interpretation of the rules, the nursing board opinion and the federal provisions cited.

    Of the two settings, the psychiatric hospital is the realistic place to begin a series. A Medicare-participating hospital must have “A formulary system” that is “established by the medical staff” and keep “Current and accurate records” of “the receipt and disposition of all scheduled drugs” (42 CFR 482.25). Under federal law ketamine falls in Schedule III, at 21 CFR 1308.13(c)(7). In practice it goes through pharmacy and therapeutics review first and then into the hospital’s controlled substance logs. Expect the medical staff to settle privileges for the psychiatrists who will order it once the formulary question is answered.

    The Kentucky Board of Nursing’s Advisory Opinion Statement #43, issued in February 2024 and revised editorially through May 2025, speaks to psychiatric ketamine directly. Giving subanesthetic doses is “within the scope of the RN who is educationally prepared and currently clinically competent,” as long as a qualified healthcare provider directly supervises the RN. Continuous monitoring is expected as well, and someone certified in ACLS has to be in the building for the full infusion and until the patient goes home. Anesthesia dosing is outside RN scope. On LPNs the opinion contradicts itself: its narrative says “It is not within the scope of practice for the (LPN) to administer subanesthetic dose Ketamine,” while its summary grid allows it under an order and direct supervision. We would follow the narrative and keep LPNs off the infusion until the Board clears that up. For Spravato, the FDA label says it “can only be administered at healthcare settings certified in the SPRAVATO REMS program” and the patient must be monitored “for at least 2 hours.”

    Involuntary patients need their own decision. 902 KAR 20:180 requires the hospital to “assure that patient rights are provided for pursuant to KRS Chapters 202A and 202B.” Chapter 202A is where Kentucky sets the criteria for involuntary hospitalization. We have not reviewed how those chapters treat consent to a medication like ketamine, so our suggestion is to limit an early protocol to voluntary patients who can consent and to let hospital counsel decide whether and how it reaches anyone else.

    A crisis unit is a poor fit for dosing. Its rule is built around short stays and stabilization, and nothing in 902 KAR 20:440 mentions infusion monitoring or an ACLS provider on site. A resident who is a candidate is better served by a referral to a prescriber’s office, with the unit noting the plan in the record.

    Passing the Patient to an Office-Based Prescriber

    Plan this on the first or second day of the stay, not at discharge. With the patient’s signed release, send the receiving prescriber the dosing log, vital sign trends and how the patient responded. A prescriber who stocks ketamine in Kentucky also takes on KASPER reporting. The Cabinet’s KASPER page says “Pharmacies and dispensing practitioners are required to report to KASPER within one business day of administering” or dispensing a controlled substance, and it asks for “administered or dispensed” information, so the receiving office should plan on reporting the doses it gives and confirm its setup with KASPER before the first patient. Ownership of that office deserves the same care, because Kentucky case law points toward a restriction. The 1943 opinion in Kendall v. Beiling, from what was then the state’s court of last resort, reversed a trial court and let stand the revocation of an optometrist’s license because he had practiced as a salaried employee of a jewelry company. In reaching that result the court said “there is scarcely any judicial dissent from the proposition that a corporation cannot lawfully engage in the practice of law or of medicine.” Optometry was the profession before the court, so treating the case as controlling for an investor-owned psychiatric prescriber’s office is our inference. A physician-owned practice that contracts with a management company for nonclinical support is the safer model, and a Kentucky health care attorney should look at it before anyone signs an operating agreement. For how a stand-alone clinic is put together, see the ketamine section of Kentucky Drug and Alcohol Outpatient Treatment Licensing.

    Paying for Round-the-Clock Mental Health Staff

    Nursing drives the budget in both settings. A psychiatric hospital needs an RN on duty every hour of every day, and a 16-bed crisis unit at full census needs four direct-care staff awake and three overnight under the 1 to 4 and 1 to 6 ratios. For the therapists and counselors, BLS puts the Kentucky median for substance abuse, behavioral disorder and mental health counselors at $54,190, with a 25th percentile of $41,730 and a 75th of $72,590 (BLS OEWS, May 2025), and the same release puts the U.S. median at $59,350. By our arithmetic, four clinicians at the Kentucky median would cost approximately $216,760 a year before benefits. Associate-level therapists, already recognized in Kentucky’s rules, are where a 24-hour program saves on that line. State rules already treat licensed professional counselor associates, certified social workers, marriage and family therapist associates and licensed psychological associates as behavioral health professionals working under clinical supervision (902 KAR 20:430 uses that category), so a licensed clinical lead overseeing associates who are still accruing their hours, at associate pay, commonly leaves the unit’s therapy budget 40 to 60 percent smaller than an all-licensed roster of therapists would require. Whether a hospital’s medical staff bylaws let associates deliver therapy on the unit is a privileging question we would settle early. On the nursing line, one RN on each shift directing several LPNs costs less than staffing every position with RNs. Bed count and acuity decide the actual roster.

    What Holds Up Kentucky Inpatient Mental Health Projects

    CON is the long pole. A psychiatric bed proposal in an area already at the 0.2 per 1,000 ceiling, or below the plan’s occupancy targets, faces an uphill review before OIG ever sees a license application. Crisis units stall for a different reason: owners treat the one-year accreditation deadline as distant, and the survey cycle catches up with them at the first renewal. And hospitals with a growing addiction census sometimes discover the 10 percent conversion rule only after they have crossed it.

    Frequently Asked Questions

    Can a Kentucky psychiatric hospital open without CON approval?

    No. KRS 216B.061 requires a CON to establish a health facility or substantially change its beds, and the exemptions in KRS 216B.020 expressly exclude licensed psychiatric inpatient beds. The 2025 State Health Plan update limits adult and geriatric psychiatric beds to 0.2 per 1,000 adult and geriatric residents in each planning area.

    Is there a 24-hour mental health option in Kentucky that skips CON?

    A residential crisis stabilization unit. KRS 216B.020 exempts licensed crisis units from CON. OIG licenses them under 902 KAR 20:440 with a limit of 16 overnight clients, a $750 initial fee and a requirement to become accredited within one year of licensure.

    How many months should a Kentucky psychiatric hospital budget for licensing?

    Our planning estimate, not a state deadline, is 12 months or more, because the CON review comes before the OIG license. After CON, OIG issues a provisional license and inspects unannounced within three months. A crisis unit without CON can move faster, and we plan those at roughly 4 to 6 months.

    Weighing a crisis unit against psychiatric beds in Kentucky? Walk us through the plan.

    Sources

    • 900 KAR 5:020 (State Health Plan incorporation): 900 KAR 5:020 (checked October 14, 2026)
    • CHFS, 2025 Update to the State Health Plan (January 2026), psychiatric and chemical dependency bed criteria and PRTF ages: State Health Plan update (PDF) (checked October 14, 2026)
    • KRS 216B.061 (Certificate of Need): KRS 216B.061 (checked October 14, 2026)
    • KRS 216B.015 (health facility definition): KRS 216B.015 (checked October 14, 2026)
    • KRS 216B.020 (CON exemptions): KRS 216B.020 (checked October 14, 2026)
    • KRS 216B.185 (hospital accreditation and inspections): KRS 216B.185 (checked October 14, 2026)
    • 900 KAR 6:020 (CON application fees): 900 KAR 6:020 (checked October 14, 2026)
    • 902 KAR 20:180 (psychiatric hospitals): 902 KAR 20:180 (checked October 14, 2026)
    • 902 KAR 20:440 (residential crisis stabilization units): 902 KAR 20:440 (checked October 14, 2026)
    • 902 KAR 20:111 (medically managed intensive inpatient withdrawal management): 902 KAR 20:111 (checked October 14, 2026)
    • 902 KAR 20:008 (OIG license procedures and fees): 902 KAR 20:008 (checked October 14, 2026)
    • 902 KAR 20 chapter listing (license categories): 902 KAR Chapter 20 (checked October 14, 2026)
    • 902 KAR 20:430 (behavioral health professional under clinical supervision): 902 KAR 20:430 (checked October 14, 2026)
    • 908 KAR 1:370 (AODE exemptions): 908 KAR 1:370 (PDF) (checked October 14, 2026)
    • CHFS OIG, Division of Health Care applications (Hospital Application, crisis unit application): Applications (checked October 14, 2026)
    • Kentucky Board of Nursing, Advisory Opinion Statement #43: Subanesthetic dosing ketamine (PDF) (checked October 14, 2026)
    • eCFR, 42 CFR 482.25: Hospital pharmaceutical services (checked October 14, 2026)
    • 21 CFR 1308.13(c)(7), via Cornell LII: Ketamine in Schedule III (checked October 14, 2026)
    • DEA, Dear Registrant letter on buprenorphine and the DATA waiver (January 12, 2023): DEA letter (PDF) (checked October 14, 2026)
    • KRS Chapter 202A (involuntary hospitalization): KRS Chapter 202A (checked October 14, 2026)
    • U.S. FDA, Spravato prescribing information and Medication Guide: Spravato label (PDF) (checked October 14, 2026)
    • CHFS OIG, KASPER: KASPER (checked October 14, 2026)
    • Kendall v. Beiling, 175 S.W.2d 489 (Ky. 1943), corporate practice of a licensed profession: CourtListener opinion (checked October 14, 2026)
    • U.S. Bureau of Labor Statistics, OEWS May 2025, Kentucky, SOC 21-1018: Kentucky OEWS and national estimates (checked October 14, 2026)
  • Kentucky Drug and Alcohol Outpatient Treatment Licensing

    Kentucky Drug and Alcohol Outpatient Treatment Licensing

    Author: A. Ant, CADC-II, Licensing & Accreditation Expert

    Disclaimer: This content is provided for general informational purposes only and should not be construed as legal, regulatory, or licensing advice. Requirements change frequently. Consult qualified professionals for guidance specific to your situation.

    Apply now: DBHDID online AODE system on Kentucky Online Gateway, “AODE Initial Licensure Application” (how to file, PDF) | Questions: chfs.aodehelpdesk@ky.gov, 502-564-0104 Option 4

    Most outpatient addiction programs in Kentucky can open without accreditation and without a Certificate of Need. Partial hospitalization is the exception on both counts. 908 KAR 1:374 says partial hospitalization services “shall be fully accredited,” naming the Joint Commission, CARF and the Council on Accreditation and leaving room for another national accreditor with comparable standards. On top of that, the CON exemption Kentucky gives outpatient behavioral health in KRS 216B.020(1) expressly leaves out “partial hospitalization programs.” An operator who sketches a PHP, IOP and outpatient ladder under one roof is really planning two projects, one of them far slower than the other.

    Every level in that ladder is licensed by the Department for Behavioral Health, Developmental and Intellectual Disabilities (DBHDID), Division of Program Integrity, which took over alcohol and other drug entity (AODE) licensing from the Office of Inspector General on April 5, 2023. Residential programs are covered in Kentucky Drug and Alcohol Inpatient Treatment Licensing. How DBHDID and OIG divide the work is mapped on the Kentucky Behavioral Health Licensing overview.

    The Outpatient Modalities in 908 KAR 1:374

    This table restates the outpatient rule, 908 KAR 1:374, and the fee and extension site provisions of 908 KAR 1:370. Entries under CON reflect how we read KRS 216B.020, not a ruling from the state.

    Kentucky licenses an AODE by modality. Each one you intend to run has to appear on the application, because a program “shall not admit clients until the program has obtained a license from the cabinet to operate the specific modality or modalities of treatment referenced on its application” (908 KAR 1:370).

    ModalityWhat the rule setsAccreditationCON
    Outpatient treatmentIncludes referral to medications for addiction treatmentNot requiredExempt
    Intensive outpatientAdults at least 9 hours a week on at least 3 days, no more than 10 patients per staff memberNot requiredExempt
    Partial hospitalizationTypically 4 to 6 weeks, at least 5 hours a day on at least 4 days a weekRequiredRequired
    Ambulatory withdrawal managementWithdrawal management delivered outpatientNot requiredExempt
    Office-based opioid treatment (non-physician-owned)Its own licensed modalityNot requiredExempt

    The rule also covers in-home services and narcotic treatment programs. Methadone clinics are a separate modality, and we don’t cover them here.

    908 KAR 1:374 was amended more recently than its companion rules. Its history line shows an amendment effective February 16, 2023, while the general rule, 908 KAR 1:370, carries a “Crt eff. 7-1-2026” entry. That is a certification under KRS 13A.3104 that the regulation stays in force without amendment, so its operative text still dates from 2019 and 2020. The cabinet has proposed an amendment to 908 KAR 1:370 to carry out HB 470’s peer support changes. It reached the Legislative Research Commission on July 13, 2026 but had not taken effect as of October 14, 2026, and its filing says “There are no new or increased fees.”

    Who Is Exempt From AODE Licensing

    The exemption list in 908 KAR 1:370 matters more to outpatient operators than to anyone else. Settings exempt from AODE licensure include self-help groups, federally qualified health centers and rural health clinics, programs licensed as chemical dependency treatment services, and “A practitioner’s private office or clinic” under KRS 216B.020(2). That last exemption is why a physician practice prescribing buprenorphine doesn’t need an AODE license, while the AODE definition does reach a non-physician-owned facility whose affiliated physician or APRN provides office-based opioid treatment to “fifty (50) percent or more of the facility’s patients.” Where the line falls for a group practice owned partly by non-clinicians is a question to put to DBHDID in writing before you sign anything, and that caution is ours rather than the rule’s.

    A clinic whose clients mostly carry a primary mental health diagnosis may belong under a different license altogether. The Office of Inspector General licenses behavioral health services organizations under 902 KAR 20:430 for clients where “The mental health disorder is the primary diagnosis and SUD is the secondary diagnosis.” That license is covered in Kentucky Mental Health Outpatient Licensing, and it brings a one-year accreditation deadline the AODE outpatient license does not.

    Fees, Extension Sites and Inspection

    An AODE pays a $500 licensure fee and renews every year at the same amount. Outpatient programs can add extension sites at $80 each, which residential programs, non-physician-owned OBOT and narcotic treatment programs are not allowed to do. A name change costs $25, a move $80 and a change of ownership $500 (908 KAR 1:370).

    Under KRS 222.231(11), DBHDID inspects before it licenses, then at least annually for nonaccredited agencies, with inspections “at least every two (2) years” for accredited ones. The rule is stricter than the statute. It says an outpatient or residential AODE “shall be subject to an annual survey visit,” and those visits are unannounced. Our reading is that an accredited outpatient program should keep budgeting for a DBHDID survey every year until the rule changes.

    MOUD in a Kentucky Outpatient Program

    908 KAR 1:374 has outpatient programs refer clients to “Medications for addiction treatment,” and treatment planning under 908 KAR 1:370 includes “pharmacological treatment modalities to manage opioid use disorder” where they apply. For a program that wants to prescribe rather than refer, the threshold question is ownership. A clinic owned by non-physicians where half or more of the patients receive office-based opioid treatment falls inside the AODE definition, so that modality has to be on its license. The prescriber needs only a standard DEA registration for buprenorphine, as DEA told registrants in its January 12, 2023 letter: “A DATA-Waiver registration is no longer required to treat patients with buprenorphine for opioid use disorder.” Methadone stays with a licensed narcotic treatment program, and a signed referral and coordination agreement with one close to where your clients live covers that gap. Naltrexone, per SAMHSA, can be prescribed and given by any practitioner licensed to prescribe.

    Opening a Ketamine Clinic in Kentucky

    Kentucky has no statute or regulation written for ketamine clinics. The no-license conclusion and the ownership structure below are our interpretation. The corporate practice discussion rests on a 1943 Kentucky appellate opinion we read in full.

    A physician office giving ketamine for depression is, on our reading, outside Kentucky’s facility licensing law. KRS 216B.020(2)(a) excludes “Private offices and clinics of physicians, dentists, and other practitioners of the healing arts,” apart from offices meeting KRS 216B.015(5) or qualifying as ambulatory surgical centers. A ketamine practice is not an AODE either, because ketamine isn’t a substance use disorder treatment. One angle we did not check is whether a clinic marketing ketamine for chronic pain could fall within Kentucky’s pain management facility law, so keep the clinic’s stated scope to psychiatric indications or ask counsel first.

    Who Can Own It

    Treat Kentucky as a state that restricts corporate practice. In Kendall v. Beiling (1943), the Court of Appeals, which was then the highest court in Kentucky, held that Kay Jewelry Company was itself practicing optometry through the optometrist it paid a salary and bonus, and it upheld the revocation of his license for aiding that practice. The opinion also observed that “there is scarcely any judicial dissent from the proposition that a corporation cannot lawfully engage in the practice of law or of medicine.” We found no Kentucky statute or regulation that answers the question head on, and because the case turned on optometry, how far it reaches a ketamine clinic in 2026 is our own reading. A cautious structure has a licensed physician owning the medical practice, with investors in a separate management services organization that charges the practice a set management fee, not a share of collections, for space, staff, billing and marketing. Kentucky’s professional entity statutes weren’t part of our review, so a Kentucky health care attorney should pick the entity and review the management agreement. If a patient begins treatment while living in a residential program, the referral and brokering cautions sit under the ketamine heading of Kentucky Drug and Alcohol Inpatient Treatment Licensing.

    Nurses, APRNs and the Drug Itself

    The Kentucky Board of Nursing’s Advisory Opinion Statement #43 lets an RN give subanesthetic ketamine for psychiatric disorders when the nurse is trained and competent and works under a qualified provider’s direct supervision. The opinion also wants an ACLS-certified provider on site for the whole infusion and until the patient leaves, with monitoring that never lapses. Running a clinic with an RN alone in the room breaks that condition. LPNs are out, according to the opinion’s narrative, even though its summary grid reads otherwise.

    APRNs in Kentucky need a CAPA-CS, a collaborative agreement for controlled substances, before writing for controlled substances in Schedules II through V (KRS 314.042), and ketamine sits in Schedule III under 21 CFR 1308.13(c)(7). After four years of controlled substance prescribing under a CAPA-CS, an APRN who has kept a DEA registration and a KASPER master account can ask the Board of Nursing to waive the agreement, though nothing changes until the Board says so in writing. The clinic needs a DEA registration for its address. KASPER reporting under 902 KAR 55:110 falls on dispensers and on health facilities holding a DEA number, which must report the Schedule II through V drugs they dispense by close of business the following business day. On doses given in the chair, the Cabinet’s KASPER page is direct: dispensing practitioners “are required to report to KASPER within one business day of administering or dispensing a controlled substance in KY.” Plan on reporting each in-office ketamine dose, and ask KASPER staff to walk you through account setup. We also did not confirm whether Kentucky requires a separate state controlled substance registration for prescribers. Esketamine (Spravato) adds a federal layer, since the clinic itself has to be enrolled as a certified Spravato REMS setting, and the FDA medication guide requires monitoring “for at least 2 hours after taking SPRAVATO.”

    Sharing a building with an AODE outpatient program is common and workable. Keep separate charts, inventory and DEA registration for the ketamine practice. Any payment tied to referrals between the two can run into KRS 222.429, Kentucky’s patient brokering statute, on the AODE side and 18 U.S.C. 220, which reaches outpatient treatment settings licensed under state law.

    Staffing an Outpatient AODE

    The general rule does most of the staffing work for outpatient programs. 908 KAR 1:370 calls for an administrator, a clinical services supervisor (an LCADC, another listed licensed professional, or a CADC carrying 4,000 post-certification clinical hours) and clinicians drawn from LCADCs, CADCs, RNs and APRNs, with case managers capped at 30 clients each. For IOP the outpatient rule adds its 10-to-1 ceiling on patients per staff member. From January 1, 2027, an AODE may employ only alcohol and drug peer support specialists registered under KRS 309.0831, and that covers people already on staff, per HB 470 (2026 Ky. Acts ch. 80).

    In the May 2025 OEWS release, BLS puts the Kentucky median for substance abuse, behavioral disorder, and mental health counselors at $54,190 a year, about $5,000 under the national $59,350. A starter outpatient team of a clinical services supervisor and three counselors runs about $216,760 a year at that median, and closer to $290,360 if all four were paid at the Kentucky 75th percentile of $72,590. Treat those as upper bounds, since Kentucky’s credential ladder lets a new clinic staff well below them. The Kentucky Board of Alcohol and Drug Counselors grants a temporary CADC for two years to bachelor’s-degree holders in any field, who then get at least two hours of supervision twice monthly. Pair those counselors with an LCADC or experienced CADC as clinical services supervisor, trading supervised hours toward full certification for lower starting pay, and an outpatient clinic usually spends 40 to 60 percent less on clinical wages than one hiring only fully certified counselors. A clinic offering medical services can similarly put one RN over a few LPNs. We size the team after the modality list is final.

    How to Submit Your AODE Outpatient Application

    Filing runs through DBHDID’s online AODE system, reached through Kentucky Online Gateway. The DBHDID flyer lays out the order: an “AODE Verification Form” per license, then the “AODE Initial Licensure Application.” Each outpatient extension site is added and paid for at $80. The Help Desk is reachable at 502-564-0104 Option 4 or 866-231-0003 Option 4 on weekdays from 8 a.m. to 4 p.m. Eastern, or chfs.aodehelpdesk@ky.gov, and the Substance Use Disorder Program Licensure Branch takes questions at BHDIDFKFTProgramLicensureBranch@ky.gov. The rule names the form “Application for License to Operate a Nonhospital-based Alcohol and Other Drug Treatment Entity (AODE),” and the 12/2018 edition can be inspected at DBHDID, 275 East Main Street, Frankfort. A partial hospitalization program will also need its accreditation documents and, before that, a Certificate of Need from the OIG Division of Certificate of Need.

    What Holds Up Kentucky Outpatient Licenses

    In our experience the slow files are the ones that add partial hospitalization late. An operator licenses outpatient and IOP, then decides to step up to PHP and discovers it needs accreditation and a CON before the first PHP client walks in. Decide on PHP at the start. The other delay is a policy manual copied from a pre-2023 template that still names OIG as the licensing agency and cites old OIG filing instructions.

    Frequently Asked Questions

    Does an outpatient SUD program in Kentucky need to be accredited?

    Only for partial hospitalization. Under 908 KAR 1:374 a PHP must hold full accreditation, whether from the Joint Commission, CARF, the Council on Accreditation or another national body with comparable standards. Standard outpatient, IOP and ambulatory withdrawal management under an AODE license have no accreditation requirement.

    Is a Certificate of Need required for outpatient addiction treatment in Kentucky?

    Generally no. The CON exemption for outpatient behavioral health treatment in KRS 216B.020(1) carves out partial hospitalization programs, so in our reading a PHP needs a certificate.

    What does a Kentucky AODE outpatient license cost?

    908 KAR 1:370 sets a $500 licensure fee that repeats at each annual renewal, and every outpatient extension site adds $80. Changing owners costs $500, and moving costs $80.

    Weighing whether partial hospitalization belongs in your first Kentucky application? Get in touch.

    Sources

  • Kentucky Drug and Alcohol Inpatient Treatment Licensing

    Kentucky Drug and Alcohol Inpatient Treatment Licensing

    Author: A. Ant, CADC-II, Licensing & Accreditation Expert

    Disclaimer: This content is provided for general informational purposes only and should not be construed as legal, regulatory, or licensing advice. Requirements change frequently. Consult qualified professionals for guidance specific to your situation.

    Apply now: “AODE Initial Licensure Application” in the online AODE system on Kentucky Online Gateway (DBHDID instructions, PDF) | Questions: AODE Help Desk, 502-564-0104 Option 4 or 866-231-0003 Option 4, chfs.aodehelpdesk@ky.gov

    Count your beds before you count anything else. Kentucky’s Certificate of Need law exempts a licensed free-standing residential substance use disorder program with sixteen or fewer beds, and the exemption stops at that number. Add a seventeenth bed, or build a hospital-style chemical dependency unit, and the project goes through CON review before a license is possible. The other thing out-of-state operators miss is who issues the license. Since April 5, 2023, residential programs licensed as alcohol and other drug entities (AODEs) answer to the Department for Behavioral Health, Developmental and Intellectual Disabilities (DBHDID), Division of Program Integrity, not the Office of Inspector General that handled them for years.

    This guide covers adult residential treatment and residential withdrawal management. Outpatient levels are in Kentucky Drug and Alcohol Outpatient Treatment Licensing. For mental health licenses and the rest of the state’s categories, start with the Kentucky Behavioral Health Licensing overview.

    Two Inpatient Routes, Two Different Agencies

    The agency transfer and both rule chapters below come from CHFS pages and the Kentucky Administrative Regulations as posted by the Legislative Research Commission.

    The CHFS Office of Inspector General (OIG) applications page says it plainly: “Effective April 5, 2023, AODE oversite transitioned to the Department for Behavioral Health.” DBHDID’s Substance Use Disorder Program Licensure Branch now licenses nonhospital residential programs under 908 KAR 1:370 (general requirements and fees) and 908 KAR 1:372 (residential). The residential rule recognizes clinically managed residential withdrawal management, residential treatment, family residential and residential transitional living, plus an adolescent program this guide doesn’t cover. The rule defines residential as “a setting that provides twenty-four (24) hour structure and support.”

    OIG still licenses a second kind of inpatient addiction program. A chemical dependency treatment service under 902 KAR 20:160 runs a structured inpatient program that can “Be hospital based or freestanding,” keeps stays under 30 days, has 8 or more beds, works under physician medical direction, and must have nursing available on a 24-hour basis plus at least one full-time RN on its roster. Medically managed intensive inpatient withdrawal management (902 KAR 20:111) has to sit inside one of those programs or a hospital. KRS 222.231 keeps the two tracks apart, since its licensing requirement doesn’t reach a program already licensed as “Chemical Dependency Treatment Services” under KRS 216B.042.

    ItemResidential AODEChemical dependency treatment service
    Licensing agencyDBHDID, Division of Program IntegrityCHFS Office of Inspector General, Division of Health Care
    Rules908 KAR 1:370 and 908 KAR 1:372902 KAR 20:160 (plus 902 KAR 20:111 for medically managed withdrawal)
    FilingOnline AODE system on Kentucky Online GatewayOIG paper application
    Medical staffing in the ruleMedical evaluation and consultation available 24 hours for withdrawal management, no medical director namedPhysician medical direction, 24-hour nursing, at least one full-time RN
    Certificate of NeedExempt at 16 or fewer bedsRequired, in our reading
    License fee$500 a yearSet in OIG’s fee schedule, which we did not confirm

    The Sixteen-Bed Line and Certificate of Need

    The statute language here is quoted from KRS 216B.015, 216B.020 and 216B.061. Which projects fall on which side of the line is our reading of those three sections together.

    Under KRS 216B.061, a new health facility, or a substantial change in an existing one’s bed count, cannot go forward “without first obtaining a certificate of need.” The definition of health facility in KRS 216B.015(13) names “chemical dependency programs” and “includes alcohol abuse, drug abuse, and mental health services.” The relief comes in KRS 216B.020(1), which exempts “licensed free-standing” “residential substance use disorder treatment programs with sixteen (16) or fewer beds.” We found no sunset on that exemption.

    So a sixteen-bed residential AODE skips CON entirely, in our reading. A larger free-standing program does not, and neither does any bed licensed under 902 KAR 20:160. Kentucky’s 2025 Update to the State Health Plan (incorporated by 900 KAR 5:020 in January 2026) caps chemical dependency beds at “a maximum rate of 11.4 beds” “per 100,000 geographic population for the plan year,” and it defines those beds by reference to 902 KAR 20:160. Whether a residential AODE over sixteen beds would be measured against that same bed need figure or reviewed some other way is something we could not settle from the plan text, so ask the OIG Division of Certificate of Need before you design around it. The filing fee schedule in 900 KAR 6:020 charges a flat $1,000 for projects spending nothing or no more than $200,000, half a percent of spending between that and $5,000,000, and $25,000 for anything larger.

    A 2025 bill that would have exempted chemical dependency treatment from CON, HB 531, was referred to the House Health Services Committee on February 21, 2025. The legislative record shows no action after that referral and no Acts chapter, so the bill died in committee.

    ASAM Criteria Without ASAM Level Numbers

    Kentucky’s AODE rules require assessment “based upon the most recent version of The American Society of Addiction Medicine (ASAM) Criteria” (908 KAR 1:370), yet 908 KAR 1:372 never assigns a 3.1, 3.5 or 3.7 label to any residential program. The license names a program type, and a referral source reading it learns nothing about level. A program that wants a level on record can get one from CARF. Its ASAM Level of Care Certification page states that certification “is available for adult Levels of Care 3.1, 3.5, and 3.7,” and ASAM’s own page says CARF runs the surveys for it. DBHDID won’t print the result on a license. A hospital case manager deciding where to discharge a patient can check it anyway. CARF’s Find a Provider tool has a Certification filter, and ticking “ASAM Level of Care 3.7” (or 3.1, or 3.5) narrows the list to certified programs. In our view it fits Kentucky’s residential treatment program. A clinically managed residential withdrawal management unit gets nothing from it, because CARF and ASAM describe the certification only in terms of residential levels 3.1, 3.5 and 3.7. A separate ASAM certification condition in Kentucky Medicaid’s rules for residential providers is a reimbursement matter outside the license, and we don’t handle it.

    What 908 KAR 1:372 Expects of the Building and the Shift

    A residential AODE must be “staffed twenty-four (24) hours per day, seven (7) days per week” with “At least one (1) staff person on duty and awake at all times.” Group sessions are capped at 12 clients per clinician. On the physical plant side, plan for at least 120 square feet for each resident, a toilet and a sink per 8 residents, and a shower or tub per 15. Residential withdrawal management adds physician-supported protocols and “Availability of medical evaluation and consultation twenty-four (24) hours per day.” The rule sets no numeric adult staffing ratio and names no medical director.

    The residential rule’s history line ends “Crt eff. 7-1-2026.” That marks a certification letter under KRS 13A.3104, filed when an agency tells the legislature a regulation will stay in effect without amendment. The text you are writing policies against dates from the 2019 rule and a 2020 technical amendment, and the certification carries a seven-year expiration of July 1, 2033.

    Medication for Opioid Use Disorder in a Residential AODE

    The AODE definition in 908 KAR 1:370 lists “Withdrawal management services, including medication-assisted treatment,” and treatment plans must cover, “If applicable,” “pharmacological treatment modalities to manage opioid use disorder.” Residential withdrawal management has to offer “Medication assisted treatment, provided onsite or through referral” (908 KAR 1:372), and residential treatment includes MAT education. We read the AODE rules looking for a clause barring refusal of clients who take MOUD and found none. Turning those clients away still costs a program its referral partners, in our experience.

    A resident on methadone keeps getting it from a narcotic treatment program, which Kentucky licenses as a separate modality under 908 KAR 1:374, so the residential program needs a written arrangement with one that will continue the doses. Buprenorphine involves less paperwork. The X-waiver is gone, and DEA’s Dear Registrant notice of January 12, 2023 confirms that “all prescriptions for buprenorphine only require a standard DEA registration number.” One Kentucky rule hasn’t caught up. 902 KAR 20:111, which governs medically managed withdrawal in OIG-licensed units, still refers to a physician with a federal waiver for opioid use disorder medications, a credential that no longer exists, so we would ask OIG how it applies that line today. SAMHSA says naltrexone “can be prescribed and administered by any practitioner licensed to prescribe medications.”

    Ketamine for Residents With Depression or PTSD in Kentucky

    Neither 908 KAR 1:370 nor 908 KAR 1:372 says anything about ketamine. The licensing conclusions in this section are our interpretation. The nursing material comes from the Kentucky Board of Nursing’s own advisory opinion.

    Kentucky licenses an AODE to run “the specific modality or modalities of treatment referenced on its application” (908 KAR 1:370), and the modality list (residential treatment, withdrawal management and the rest) contains no medication categories. A ketamine series for a resident with treatment-resistant depression would be part of that resident’s medical care rather than a new modality, which is how we read it. The risk is that DBHDID sees it differently and treats it as a service your application never described. Email the licensure branch at BHDIDFKFTProgramLicensureBranch@ky.gov with the protocol before ordering any drug, and keep the reply.

    What the Board of Nursing Allows

    Kentucky’s nursing board has addressed this directly. Advisory Opinion Statement #43 (issued February 2024, edited November 2024 and May 2025) puts subanesthetic ketamine for psychiatric disorders “within the scope of the RN who is educationally prepared and currently clinically competent,” provided a qualified provider directly supervises. Monitoring has to be continuous, and somebody certified in ACLS must be in the building for the entire infusion and stay until the patient is discharged. The narrative is blunt about practical nurses: “It is not within the scope of practice for the (LPN) to administer subanesthetic dose Ketamine.” The opinion’s summary grid reads more loosely on LPNs, which contradicts the narrative, and we would staff to the stricter text. A residential house built around one RN and several LPNs therefore can’t hand ketamine to the LPN on shift, and a 902 KAR 20:160 unit with physician direction and 24-hour nursing is the setting that already matches AOS #43.

    DEA, KASPER and Prescribers

    Because 21 CFR 1308.13(c)(7) places ketamine on the Schedule III list, our reading is that whoever orders it for residents should hold a DEA registration at the residential address. Under 902 KAR 55:110, dispensers and health facilities holding a DEA number must report dispensed Schedule II through V drugs to KASPER “no later than close of business on the business day immediately following the dispensing.” The Cabinet’s KASPER page settles the in-house question for practitioners, saying they must report “within one business day of administering or dispensing a controlled substance in KY,” so a residence that gives ketamine on site should expect to report each dose. An APRN needs a CAPA-CS before prescribing any Schedule II through V drug under KRS 314.042, with a Board exemption route open only after four years under a CAPA-CS. Esketamine nasal spray is a separate federal track. Spravato “can only be administered at healthcare settings certified in the SPRAVATO REMS program,” according to its FDA medication guide, which also tells patients a provider “must monitor you for at least 2 hours after taking SPRAVATO.”

    Picking Residents

    Ketamine isn’t an opioid use disorder medication, so offering it does nothing toward the MAT access 908 KAR 1:372 expects. A resident still in early withdrawal is a poor candidate, because nobody can separate drug effect from withdrawal noise. We would look at people whose depression or trauma symptoms outlasted stabilization and a standard antidepressant trial. Anyone whose own drug history includes dissociatives (ketamine itself, PCP and similar drugs) is someone we would leave out. Your medical director, not the license, sets those lines.

    When the Resident Goes Home Mid-Series

    Plan for the rest of the series to happen at an outpatient ketamine practice, and plan who owns it with care. In 1943 the Court of Appeals, then Kentucky’s highest court, decided Kendall v. Beiling, 295 Ky. 782, 175 S.W.2d 489. A jewelry corporation had put a licensed optometrist on salary to run its optical department, and the court reinstated the State Board of Health’s revocation of his license for helping the corporation practice without one. On the way there it wrote that “there is scarcely any judicial dissent from the proposition that a corporation cannot lawfully engage in the practice of law or of medicine.” The dispute itself was about optometry, so applying it to a lay-owned ketamine clinic today is our reading rather than anything the court decided. A 2026 resolution the Greater Louisville Medical Society brought to the Kentucky Medical Association leans on the same case. The cautious route is a practice owned by a Kentucky-licensed physician, with a separate management services organization handling space, staff and billing under contract, and a Kentucky health care attorney reviewing the arrangement before money changes hands. For what the outpatient clinic itself needs, read the ketamine part of Kentucky Drug and Alcohol Outpatient Treatment Licensing.

    Kentucky added its own patient brokering crime in 2024. KRS 222.429 bars soliciting or receiving remuneration for referring someone to a treatment program and bars paying anyone “In exchange for an individual using the services of that treatment program.” Each offense is a Class A misdemeanor, rising to a Class D felony at $1,000 or more, and conduct protected under the federal exceptions in 18 U.S.C. 220(b) is carved out. The federal statute, 18 U.S.C. 220, covers non-hospital settings providing “residential treatment” for substance use “pursuant to licensure or certification under State law.” Each occurrence there can draw as much as $200,000 in fines and a 10-year prison term. Any arrangement between your beds and the clinic gets a lawyer’s review first.

    Staffing a Kentucky Residential Program

    908 KAR 1:370 requires an administrator for day-to-day operation and a clinical services supervisor, who can be an LCADC, one of the listed licensed professionals, or a CADC who has logged 4,000 hours of clinical work since certification. Clinicians can include LCADCs, CADCs, RNs and APRNs, and a case manager’s caseload can’t exceed 30 clients. Peer support has a hard date coming. HB 470 (2026 Ky. Acts ch. 80, signed April 10, 2026) says that “Beginning January 1, 2027” an AODE may “only employ an alcohol and drug peer support specialist who is registered under KRS 309.0831,” and it repealed the temporary peer credential. Check every peer’s registration before New Year’s.

    Kentucky counselor pay runs below the national figure. BLS reports a statewide median of $54,190 for substance abuse, behavioral disorder, and mental health counselors (OEWS, May 2025), while the U.S. median in that release is $59,350, with Kentucky’s 25th and 75th percentiles at $41,730 and $72,590. A clinical services supervisor and five counselors paid at the state median come to roughly $325,140 a year, before overnight awake staff, nursing and benefits. Few residential programs in Kentucky carry that full number, because the state’s counselor credentials are built in stages. The Kentucky Board of Alcohol and Drug Counselors issues a two-year temporary CADC to applicants with a bachelor’s degree in any field, with supervision of at least 2 hours twice a month, and the LCADC asks for a master’s degree and 2,000 hours of experience. Put a clinical services supervisor in charge of temporary CADCs who are earning their full credential, pay them less than certified counselors while they log the hours, and the counseling payroll typically comes in 40 to 60 percent under what you would pay if every counselor already held the full credential. One RN directing several LPNs covers most nursing tasks, leaving ketamine and other RN-only work with the RN. We set the actual roster once the bed count and the withdrawal management decision are final.

    Inspections and Accreditation

    Accreditation is optional for a residential AODE. Its main licensing payoff sits in KRS 222.231(11), which says that for an agency “fully accredited by the Joint Commission, Commission on Accreditation of Rehabilitation Facilities,” COA or a comparable body, “the cabinet shall inspect the agency at least every two (2) years.” The rule hasn’t followed. 908 KAR 1:370 still says “An outpatient or residential AODE shall be subject to an annual survey visit,” unannounced, so in our reading an accredited program should still expect DBHDID every year. The statute also requires an inspection before the first license, and the rule says a program “shall not admit clients until the program has obtained a license” for each modality on its application.

    How to Submit Your DBHDID Residential Application

    DBHDID’s instructions point AODE applicants to its online AODE system on Kentucky Online Gateway (KOG), and an AODE needs a KOG account to use it. The flyer doesn’t say whether paper filings are still accepted, so ask the Help Desk if you were planning on one. Its instruction flyer says to complete an “AODE Verification Form” for each license first, then select “AODE Initial Licensure Application.” Renewals and changes later run through “Annual Re-licensure/Change applications” in the same system. The AODE Help Desk answers at 502-564-0104 Option 4 or 866-231-0003 Option 4, Monday through Friday 8 a.m. to 4 p.m. Eastern, and at chfs.aodehelpdesk@ky.gov. Licensing questions go to BHDIDFKFTProgramLicensureBranch@ky.gov.

    The license fee is $500 and renews annually at the same amount (908 KAR 1:370). Residential programs can’t use the $80 extension sites outpatient AODEs rely on, so each residential location is licensed in its own right. A hospital-type chemical dependency unit applies to OIG instead, using the Chemical Dependency Treatment Service Application listed on the OIG applications page, after its Certificate of Need is in hand. OIG’s Division of Health Care is at 275 East Main Street, 5E-A, Frankfort, KY 40621, 502-564-7963.

    Where Kentucky Residential Projects Stall

    Older guidance is still circulating that tells applicants to mail an AODE packet to OIG at 275 East Main Street. That instruction stopped being right in April 2023, and in our experience a packet sent to the wrong office costs weeks before anyone redirects it. The other setback we see is a bed plan drawn at 18 or 20 to improve the economics, which turns a CON-exempt project into one that needs a certificate first. Settle the bed count before the lease.

    Frequently Asked Questions

    Does a residential SUD program in Kentucky need a Certificate of Need?

    Not at 16 beds or fewer. KRS 216B.020(1) exempts licensed free-standing residential substance use disorder treatment programs with sixteen or fewer beds. In our reading a larger free-standing program, and any chemical dependency unit licensed by OIG under 902 KAR 20:160, needs a certificate first.

    Who licenses residential addiction treatment in Kentucky now?

    Since April 5, 2023, nonhospital residential programs (AODEs) are licensed by the Department for Behavioral Health, Developmental and Intellectual Disabilities through its online AODE system. Inpatient chemical dependency units run on the 902 KAR 20:160 model, hospital based or freestanding, remain with the Office of Inspector General.

    How long does licensing a Kentucky residential AODE take?

    The rules set no decision deadline. For planning we estimate four to six months when the program stays at 16 beds or fewer, and a year or longer if a Certificate of Need has to come first. DBHDID has to inspect before issuing the license, and the program can’t admit anyone until it is licensed.

    Deciding between a 16-bed AODE and a bigger build that needs CON? We can talk it through.

    Sources

Top